Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone H3K4 monomethyltransferase activity	SETD1A KMT2C KMT2D	1.80e-05	8	139	3	GO:0140945
GeneOntologyMolecularFunction	histone H3K4 trimethyltransferase activity	SETD1A KMT2C KMT2D	3.82e-05	10	139	3	GO:0140999
GeneOntologyMolecularFunction	latrotoxin receptor activity	ADGRL1 ADGRL2	4.81e-05	2	139	2	GO:0016524
GeneOntologyMolecularFunction	muscle alpha-actinin binding	SYNPO2 PDLIM7 LDB3	1.41e-04	15	139	3	GO:0051371
GeneOntologyMolecularFunction	transcription coregulator activity	MIER2 TCF4 SERTAD2 MED1 SF1 RNF14 PHF2 KMT2C PRDM8 KMT2D RBM14 NCOA1 KAT6B	1.55e-04	562	139	13	GO:0003712
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	MYC TCF4 RELA CREB5 BNC1 ZNF750 KMT2D EGR1 EGR2 NR5A2 ELF4 FEV FOXC1	1.66e-04	566	139	13	GO:0001216
GeneOntologyMolecularFunction	chromatin binding	TCF4 PER1 RELA REST MED1 ZNF750 PRDM8 ATXN1 EGR1 EGR2 ZC3H4 NR5A2 NCOA1 KAT6B FOXC1	2.01e-04	739	139	15	GO:0003682
GeneOntologyMolecularFunction	histone modifying activity	MIER2 SETD1A PHF2 KMT2C PRDM8 KMT2D NCOA1 KAT6B	2.06e-04	229	139	8	GO:0140993
GeneOntologyMolecularFunction	actinin binding	SYNPO2 PDLIM7 RELA LDB3	2.25e-04	43	139	4	GO:0042805
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	SETD1A KMT2C PRDM8 KMT2D	2.46e-04	44	139	4	GO:0140938
GeneOntologyMolecularFunction	transcription coactivator activity	SERTAD2 MED1 RNF14 PHF2 KMT2C KMT2D RBM14 NCOA1 KAT6B	2.77e-04	303	139	9	GO:0003713
GeneOntologyMolecularFunction	promoter-specific chromatin binding	MED1 ZNF750 EGR1 ZC3H4 FOXC1	2.86e-04	83	139	5	GO:1990841
GeneOntologyMolecularFunction	histone H3K4 methyltransferase activity	SETD1A KMT2C KMT2D	3.45e-04	20	139	3	GO:0042800
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	MIER2 MAPK8IP1 TCF4 SYNPO2 DVL2 BLNK SERTAD2 ATG2A MED1 SF1 RNF14 PHF2 KMT2C PRDM8 KMT2D RBM14 NCOA1 KAT6B BTRC	4.39e-04	1160	139	19	GO:0030674
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	MYC TCF4 RELA CREB5 ZNF750 KMT2D EGR1 EGR2 NR5A2 ELF4 FEV FOXC1	5.54e-04	560	139	12	GO:0001228
GeneOntologyMolecularFunction	core promoter sequence-specific DNA binding	MYC RELA REST EGR1	5.82e-04	55	139	4	GO:0001046
GeneOntologyMolecularFunction	RNA polymerase II core promoter sequence-specific DNA binding	RELA REST EGR1	6.79e-04	25	139	3	GO:0000979
GeneOntologyMolecularFunction	dihydropyrimidinase activity	DPYSL3 CRMP1	7.09e-04	6	139	2	GO:0004157
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	MYC TCF4 PER1 CC2D1A HIC2 RELA REST MED1 CREB5 HIVEP3 ZNF750 ZNF394 EGR1 EGR2 NR5A2 ELF4 FEV TET3 FOXC1	1.02e-03	1244	139	19	GO:0000978
GeneOntologyMolecularFunction	filamin binding	DPYSL3 SYNPO2 CRMP1	1.06e-03	29	139	3	GO:0031005
GeneOntologyMolecularFunction	molecular adaptor activity	MIER2 MAPK8IP1 TCF4 SYNPO2 DVL2 BLNK SERTAD2 ATG2A MED1 SF1 RNF14 PHF2 KMT2C PRDM8 KMT2D RBM14 NCOA1 SCIMP KAT6B BTRC	1.14e-03	1356	139	20	GO:0060090
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	MYC TCF4 PER1 CC2D1A HIC2 RELA REST MED1 ASCL3 CREB5 HIVEP3 ZNF750 ZNF394 EGR1 EGR2 NR5A2 NCOA1 ELF4 FEV TET3 FOXC1	1.16e-03	1459	139	21	GO:0000977
GeneOntologyMolecularFunction	alpha-actinin binding	SYNPO2 PDLIM7 LDB3	1.29e-03	31	139	3	GO:0051393
GeneOntologyMolecularFunction	protein-lysine N-methyltransferase activity	SETD1A KMT2C PRDM8 KMT2D	1.30e-03	68	139	4	GO:0016279
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	MYC TCF4 PER1 CC2D1A HIC2 RELA REST MED1 CREB5 HIVEP3 ZNF750 ZNF394 EGR1 EGR2 NR5A2 ELF4 FEV TET3 FOXC1	1.31e-03	1271	139	19	GO:0000987
GeneOntologyMolecularFunction	lysine N-methyltransferase activity	SETD1A KMT2C PRDM8 KMT2D	1.37e-03	69	139	4	GO:0016278
GeneOntologyMolecularFunction	histone methyltransferase activity	SETD1A KMT2C PRDM8 KMT2D	1.52e-03	71	139	4	GO:0042054
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	MYC SETD1A TCF4 PER1 RELA REST MED1 RNF14 EGR2 NCOA1 FOXC1	2.54e-03	582	139	11	GO:0140297
GeneOntologyMolecularFunction	transcription coregulator binding	MYC PER1 RELA MED1 NR5A2	2.99e-03	140	139	5	GO:0001221
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	MYC TCF4 BTBD18 DVL2 PER1 RELA REST MED1 ASCL3 CREB5 ZNF750 KMT2C ABLIM1 KMT2D SLC11A1 ATXN1 EGR1 EGR2 NR5A2 RBM14 NCOA1 ELF4 FEV KAT6B TET3 FOXC1	1.57e-06	1390	138	26	GO:0045944
GeneOntologyBiologicalProcess	regulation of cellular component biogenesis	C15orf62 SLAIN2 SPHK2 DPYSL3 SYNPO2 PDCD6IP MAP2 ZDHHC5 ADGRL1 CC2D1A REST ATG2A STAM LCAT ATP13A2 CRMP1 ZNF750 TJP1 WASF2 RBM14 LRP1 ADGRL2 PLK4	3.97e-06	1189	138	23	GO:0044087
GeneOntologyBiologicalProcess	transcription initiation-coupled chromatin remodeling	SETD1A SPHK2 PHF2 EGR1 RBM14 TET3	4.80e-06	65	138	6	GO:0045815
GeneOntologyBiologicalProcess	positive regulation of gene expression, epigenetic	SETD1A SPHK2 PHF2 EGR1 RBM14 TET3	6.26e-06	68	138	6	GO:0141137
GeneOntologyBiologicalProcess	regulation of nervous system development	MYC SEMA4F ARHGAP32 MAP2 FXR2 SPART ADGRL1 RELA REST NF1 ATXN1 EGR2 LRP1 ADGRL2 MYRF	1.97e-05	625	138	15	GO:0051960
GeneOntologyBiologicalProcess	transcription initiation at RNA polymerase II promoter	MYC SETD1A SPHK2 MED1 PHF2 EGR1 RBM14 TET3	3.68e-05	186	138	8	GO:0006367
GeneOntologyBiologicalProcess	regulation of neurogenesis	MYC SEMA4F ARHGAP32 MAP2 FXR2 SPART RELA REST NF1 ATXN1 EGR2 LRP1 MYRF	4.34e-05	515	138	13	GO:0050767
GeneOntologyBiologicalProcess	protein-DNA complex organization	MYC MIER2 SETD1A TCF4 SPHK2 PER1 RELA REST MED1 PHF2 KMT2C PRDM8 KMT2D EGR1 RBM14 NCOA1 KAT6B TET3	1.23e-04	999	138	18	GO:0071824
GeneOntologyBiologicalProcess	regulation of cell development	MYC SEMA4F SETD1A ARHGAP32 MAP2 FXR2 SPART RELA REST MED1 BNC1 NF1 ATXN1 ZFP36L2 EGR2 LRP1 KAT6B MYRF LILRB5	1.28e-04	1095	138	19	GO:0060284
GeneOntologyBiologicalProcess	gamma-aminobutyric acid secretion, neurotransmission	BEST1 NF1	1.33e-04	3	138	2	GO:0061534
GeneOntologyBiologicalProcess	chromatin remodeling	MYC MIER2 SETD1A SPHK2 PER1 REST PHF2 KMT2C PRDM8 KMT2D EGR1 RBM14 NCOA1 KAT6B TET3	1.35e-04	741	138	15	GO:0006338
GeneOntologyBiologicalProcess	positive regulation of cellular component biogenesis	C15orf62 SLAIN2 DPYSL3 SYNPO2 PDCD6IP ZDHHC5 ADGRL1 ATG2A STAM ATP13A2 WASF2 ADGRL2 PLK4	1.48e-04	582	138	13	GO:0044089
GeneOntologyBiologicalProcess	positive regulation of exosomal secretion	PDCD6IP STAM ATP13A2	1.54e-04	16	138	3	GO:1903543
GeneOntologyBiologicalProcess	DNA-templated transcription initiation	MYC SETD1A SPHK2 MED1 PHF2 EGR1 RBM14 TET3	1.67e-04	231	138	8	GO:0006352
GeneOntologyCellularComponent	actin cytoskeleton	ARHGAP32 DPYSL3 SYNPO2 PDCD6IP MAP2 PDLIM7 CRMP1 DOCK5 ABLIM1 LDB3 TJP1 AMOT WASF2	1.36e-04	576	140	13	GO:0015629
GeneOntologyCellularComponent	actomyosin	SYNPO2 PDCD6IP PDLIM7 ABLIM1 LDB3 AMOT	1.38e-04	117	140	6	GO:0042641
Domain	PDZ	SYNPO2 PDLIM7 DVL2 MAST2 LDB3 TJP1 CNKSR3 FRMPD3	8.09e-06	141	134	8	PF00595
Domain	PDZ	SYNPO2 PDLIM7 DVL2 MAST2 LDB3 TJP1 CNKSR3 FRMPD3	1.15e-05	148	134	8	SM00228
Domain	-	SYNPO2 PDLIM7 DVL2 MAST2 LDB3 TJP1 CNKSR3 FRMPD3	1.27e-05	150	134	8	2.30.42.10
Domain	PDZ	SYNPO2 PDLIM7 DVL2 MAST2 LDB3 TJP1 CNKSR3 FRMPD3	1.34e-05	151	134	8	PS50106
Domain	PDZ	SYNPO2 PDLIM7 DVL2 MAST2 LDB3 TJP1 CNKSR3 FRMPD3	1.40e-05	152	134	8	IPR001478
Domain	Latrophilin	ADGRL1 ADGRL2	1.53e-04	3	134	2	PF02354
Domain	DUF3446	EGR1 EGR2	1.53e-04	3	134	2	PF11928
Domain	DUF3446	EGR1 EGR2	1.53e-04	3	134	2	IPR021849
Domain	GPCR_2_latrophilin_rcpt_C	ADGRL1 ADGRL2	1.53e-04	3	134	2	IPR003334
Domain	SH3	CASS4 MAPK8IP1 ARHGAP32 ARHGAP9 STAM SLA DOCK5 TJP1	1.68e-04	216	134	8	SM00326
Domain	SH3	CASS4 MAPK8IP1 ARHGAP32 ARHGAP9 STAM SLA DOCK5 TJP1	1.68e-04	216	134	8	PS50002
Domain	SH3_1	CASS4 MAPK8IP1 ARHGAP32 ARHGAP9 STAM SLA DOCK5	1.83e-04	164	134	7	PF00018
Domain	Post-SET_dom	SETD1A KMT2C KMT2D	1.89e-04	16	134	3	IPR003616
Domain	PostSET	SETD1A KMT2C KMT2D	1.89e-04	16	134	3	SM00508
Domain	POST_SET	SETD1A KMT2C KMT2D	1.89e-04	16	134	3	PS50868
Domain	-	RBM26 ZFP36L2 RBM27 ZC3H4	1.89e-04	40	134	4	4.10.1000.10
Domain	SH3_domain	CASS4 MAPK8IP1 ARHGAP32 ARHGAP9 STAM SLA DOCK5 TJP1	1.91e-04	220	134	8	IPR001452
Domain	PHD	DIDO1 PHF2 KMT2C KMT2D KAT6B	2.04e-04	75	134	5	PF00628
Domain	Znf_PHD-finger	DIDO1 PHF2 KMT2C KMT2D KAT6B	2.60e-04	79	134	5	IPR019787
Domain	SET	SETD1A KMT2C PRDM8 KMT2D	3.27e-04	46	134	4	SM00317
Domain	zf-CCCH	RBM26 ZFP36L2 RBM27 ZC3H4	4.18e-04	49	134	4	PF00642
Domain	SET_dom	SETD1A KMT2C PRDM8 KMT2D	4.52e-04	50	134	4	IPR001214
Domain	SET	SETD1A KMT2C PRDM8 KMT2D	4.52e-04	50	134	4	PS50280
Domain	PHD	DIDO1 PHF2 KMT2C KMT2D KAT6B	4.52e-04	89	134	5	SM00249
Domain	Znf_PHD	DIDO1 PHF2 KMT2C KMT2D KAT6B	5.01e-04	91	134	5	IPR001965
Domain	FYrich_C	KMT2C KMT2D	5.04e-04	5	134	2	IPR003889
Domain	FYrich_N	KMT2C KMT2D	5.04e-04	5	134	2	IPR003888
Domain	FYRC	KMT2C KMT2D	5.04e-04	5	134	2	SM00542
Domain	FYRN	KMT2C KMT2D	5.04e-04	5	134	2	SM00541
Domain	Gal_Lectin	ADGRL1 ADGRL2	5.04e-04	5	134	2	PF02140
Domain	PWI	RBM26 RBM27	5.04e-04	5	134	2	PF01480
Domain	-	RBM26 RBM27	5.04e-04	5	134	2	1.20.1390.10
Domain	GPCR_2_latrophilin	ADGRL1 ADGRL2	5.04e-04	5	134	2	IPR003924
Domain	Lectin_gal-bd_dom	ADGRL1 ADGRL2	5.04e-04	5	134	2	IPR000922
Domain	FYRN	KMT2C KMT2D	5.04e-04	5	134	2	PF05964
Domain	FYRC	KMT2C KMT2D	5.04e-04	5	134	2	PF05965
Domain	FYRC	KMT2C KMT2D	5.04e-04	5	134	2	PS51543
Domain	FYRN	KMT2C KMT2D	5.04e-04	5	134	2	PS51542
Domain	SUEL_LECTIN	ADGRL1 ADGRL2	5.04e-04	5	134	2	PS50228
Domain	PWI_dom	RBM26 RBM27	5.04e-04	5	134	2	IPR002483
Domain	ZF_PHD_2	DIDO1 PHF2 KMT2C KMT2D KAT6B	6.10e-04	95	134	5	PS50016
Domain	ZF_PHD_1	DIDO1 PHF2 KMT2C KMT2D KAT6B	6.39e-04	96	134	5	PS01359
Domain	Hydantoinase/dihydroPyrase	DPYSL3 CRMP1	7.52e-04	6	134	2	IPR011778
Domain	Znf_CCCH	RBM26 ZFP36L2 RBM27 ZC3H4	7.96e-04	58	134	4	IPR000571
Domain	ZF_C3H1	RBM26 ZFP36L2 RBM27 ZC3H4	7.96e-04	58	134	4	PS50103
Domain	-	DPYSL3 CRMP1	1.39e-03	8	134	2	2.30.40.10
Domain	Amidohydro_1	DPYSL3 CRMP1	2.21e-03	10	134	2	PF01979
Domain	Metal-dep_hydrolase_composite	DPYSL3 CRMP1	2.21e-03	10	134	2	IPR011059
Domain	GAIN_dom_N	ADGRL1 ADGRL2	2.69e-03	11	134	2	IPR032471
Domain	Amidohydro-rel	DPYSL3 CRMP1	2.69e-03	11	134	2	IPR006680
Domain	GAIN	ADGRL1 ADGRL2	2.69e-03	11	134	2	PF16489
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	MYC MIER2 TCF4 RBM26 SERTAD2 ZDHHC5 DIDO1 RELA REST SF1 HIVEP3 PHF2 ZNF750 ABLIM1 ZNF394 ATXN1 ZFP36L2 EGR1 NR5A2 NCOA1 TSC22D4 KAT6B ZNF687	2.29e-13	808	141	23	20412781
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SLAIN2 SETD1A PDCD6IP HECTD4 SERTAD2 SPART DIDO1 HIC2 ATG2A KMT2C RBM27 ZC3H4 AMOT RPRD2 ADGRL2 KAT6B ZNF687	6.04e-11	529	141	17	14621295
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	MYC C15orf62 SETD1A ARHGAP32 SYNPO2 PDCD6IP PDLIM7 BEAN1 SCYL1 ATG2A DOCK5 FAM193A EGR1 EGR2 ARRDC3	2.80e-10	430	141	15	35044719
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TANC2 SLAIN2 ARHGAP32 DPYSL3 PDCD6IP MAP2 CC2D1A MAST2 ABLIM1 NF1 FAM13A ATXN1 ZFP36L2 TJP1 AMOT CNKSR3 RBM14 TSC22D4 PLK4 KLC3	3.47e-10	861	141	20	36931259
Pubmed	A census of human transcription factors: function, expression and evolution.	MYC TCF4 HIC2 RELA REST ASCL3 CREB5 HIVEP3 BNC1 KMT2D ZFP36L2 EGR1 EGR2 NR5A2 NCOA1 ELF4 FEV TSC22D4 MYRF FOXC1	8.68e-10	908	141	20	19274049
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TANC2 SEMA4F SETD1A SPHK2 HECTD4 ZDHHC5 PER1 ADGRL1 CC2D1A GRID1 ATG2A MAST2 ATP13A2 MYORG HIVEP3 KMT2C KMT2D ZFP36L2 MYRF PRRT4 ZNF687	4.33e-09	1105	141	21	35748872
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	BEST1 TPCN2 PDCD6IP MAP2 HECTD4 BLNK FBXL17 ADGRL1 DOCK5 HIVEP3 PHF2 KMT2C ABLIM1 FAM13A ATXN1 TJP1 SEL1L3 KIAA1328 LRP1 RPRD2 TSC22D4 KAT6B CTDSPL TET3	7.49e-09	1489	141	24	28611215
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SLAIN2 SETD1A DPYSL3 PDLIM7 RBM26 DIDO1 CC2D1A MED1 KMT2C ABLIM1 KMT2D RBM27 TJP1 AMOT RPRD2	7.69e-09	549	141	15	38280479
Pubmed	KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4.	SLAIN2 DPYSL3 RBM26 DIDO1 SF1 RBM27 RBM14 RPRD2	6.40e-08	130	141	8	35545047
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TANC2 MAPK8IP1 ARHGAP32 PDCD6IP FXR2 HECTD4 DVL2 DIDO1 CRMP1 ABLIM1 NF1 ZNF394 TJP1 ZC3H4 WASF2 CNKSR3 LRP1 FRMPD3	7.81e-08	963	141	18	28671696
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	ARHGAP32 PDLIM7 DVL2 ZDHHC5 STAM ABLIM1 FAM193A TJP1 AMOT RBM14	1.34e-07	263	141	10	34702444
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MYC TANC2 SLAIN2 FXR2 NTAQ1 BTBD18 DVL2 PER1 HIC2 MAST2 PHF2 NAA35 ATXN1 ZC3H4 LRP1 ADGRL2 KAT6B ZNF687 FOXC1	1.40e-07	1116	141	19	31753913
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	SETD1A RBM26 SCYL1 DIDO1 MED1 SF1 KMT2D ZFP36L2 ZC3H4 KAT6B ZNF687	1.62e-07	341	141	11	32971831
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	MYC TCF4 SERTAD2 DIDO1 REST SF1 RNF14 KMT2C ABLIM1 LDB3 NR5A2 NCOA1 TSC22D4 KAT6B ZNF687	2.15e-07	709	141	15	22988430
Pubmed	Human transcription factor protein interaction networks.	MYC SETD1A TCF4 ARHGAP32 PSMB4 DIDO1 CC2D1A HIC2 RELA PHF2 KMT2C KMT2D LIN37 ATXN1 RBM27 NCOA1 RPRD2 ELF4 FEV ZNF687 FOXC1	3.35e-07	1429	141	21	35140242
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	MYC TCF4 PSMB4 RBM26 DVL2 PER1 HIC2 RELA CREB5 KMT2D LIN37 WASF2 LRP1 ADGRL2 BTRC FOXC1	4.41e-07	857	141	16	25609649
Pubmed	Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism.	MYC EGR1 EGR2	6.48e-07	5	141	3	21187408
Pubmed	The oncogenic STP axis promotes triple-negative breast cancer via degradation of the REST tumor suppressor.	SCYL1 REST BTRC	6.48e-07	5	141	3	25453754
Pubmed	Id3 Restricts γδ NKT Cell Expansion by Controlling Egr2 and c-Myc Activity.	MYC EGR1 EGR2	6.48e-07	5	141	3	30012846
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	SLAIN2 PDCD6IP ZDHHC5 SCYL1 CC2D1A RELA DOCK5 TJP1 ZC3H4 AMOT WASF2 RBM14 RELL1 ADGRL2 PCDH10	6.82e-07	777	141	15	35844135
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	SLAIN2 KMT2D FAM193A ATXN1 RBM27 TJP1 LRP1 RPRD2	9.16e-07	184	141	8	32908313
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	RBM26 DIDO1 CC2D1A STAM MED1 SF1 FAM13A RBM27 ZC3H4 RBM14 RPRD2 ZNF687	1.08e-06	503	141	12	16964243
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	MYC SETD1A DIDO1 MED1 SF1 RBM27 RPRD2	1.32e-06	134	141	7	25452129
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	DPYSL3 RBM26 DVL2 SPART DIDO1 CC2D1A STAM MED1 SF1 ABLIM1 FAM193A RBM27 TJP1 ZC3H4 WASF2 RPRD2	1.36e-06	934	141	16	33916271
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	MYC TCF4 FXR2 SERTAD2 PER1 RELA REST MED1 ASCL3 RNF14 PHF2 EGR1 NR5A2 RBM14 TSC22D4	3.02e-06	877	141	15	20211142
Pubmed	The plasticity of WDR5 peptide-binding cleft enables the binding of the SET1 family of histone methyltransferases.	SETD1A KMT2C KMT2D	3.60e-06	8	141	3	22266653
Pubmed	Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases.	SETD1A KMT2C KMT2D	3.60e-06	8	141	3	23130995
Pubmed	New nomenclature for chromatin-modifying enzymes.	SETD1A KMT2C KMT2D NCOA1 KAT6B	3.60e-06	57	141	5	18022353
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	PDCD6IP DVL2 DIDO1 RELA MED1 CRMP1 ABLIM1 ZC3H4 RPRD2 TSC22D4 ZNF687	3.87e-06	472	141	11	38943005
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	HIC2 PHF2 KMT2C ABLIM1 ZC3H4 AMOT RPRD2 KAT6B	4.10e-06	225	141	8	12168954
Pubmed	A human MAP kinase interactome.	MYC ARHGAP32 SYNPO2 PDCD6IP ADGRL1 RELA KMT2C ABLIM1 ATXN1 EGR1 KIAA1328	5.10e-06	486	141	11	20936779
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	MYC TANC2 SLAIN2 PDLIM7 RBM26 DVL2 SCYL1 PER1 CC2D1A RELA ATG2A ABLIM1 LIN37 ZFP36L2 TJP1 RPRD2	5.21e-06	1038	141	16	26673895
Pubmed	Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.	SETD1A KMT2C KMT2D	5.38e-06	9	141	3	22665483
Pubmed	Physical Interactions and Functional Coordination between the Core Subunits of Set1/Mll Complexes and the Reprogramming Factors.	MYC SETD1A KMT2D	5.38e-06	9	141	3	26691508
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ARHGAP32 DPYSL3 PDLIM7 ZDHHC5 RELA STAM PHF2 KMT2D TJP1 KIAA1328 RELL1 ADGRL2 CTDSPL PLK4 BTRC FOXC1	5.95e-06	1049	141	16	27880917
Pubmed	Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions.	MYC PDCD6IP MAP2 WASF2 RBM14 PIP4P2	6.04e-06	110	141	6	37219487
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	ARHGAP32 ZDHHC5 SPART SF1 RBM27 RBM14 RPRD2	9.33e-06	180	141	7	35198878
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	SEMA4F LIAS FXR2 ARHGAP9 HIC2 SF1 DOCK5 KMT2C DQX1 AMOT PCDH10 SERPINA9 TMEM200C	1.02e-05	736	141	13	29676528
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	SLAIN2 ARHGAP32 DPYSL3 FXR2 PDLIM7 DVL2 CC2D1A RELA ATG2A MAST2 TJP1 WASF2 CNKSR3 RBM14	1.04e-05	853	141	14	28718761
Pubmed	Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing.	MIER2 SEMA4F TCF4 BEST1 FXR2 SCYL1 SPART LDB3 EGR2 RBM14 PLK4 BTRC KLC3	1.11e-05	742	141	13	26871637
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	SETD1A FXR2 HECTD4 DVL2 MED1 NF1 RBM27 AMOT RPRD2 ZNF687	1.34e-05	440	141	10	34244565
Pubmed	Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes.	SETD1A KMT2C KMT2D	1.40e-05	12	141	3	27563068
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	RBM26 MED1 KMT2D ATXN1 RBM27 ZC3H4 NCOA1 RPRD2	1.47e-05	268	141	8	33640491
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	TANC2 PDLIM7 STAM MAST2 ABLIM1 NF1 FAM193A ZFP36L2 TJP1 AMOT	1.51e-05	446	141	10	24255178
Pubmed	c-Myc represses the murine Nramp1 promoter.	MYC SLC11A1	1.63e-05	2	141	2	12196193
Pubmed	Inhibition of the RelA(p65) NF-kappaB subunit by Egr-1.	RELA EGR1	1.63e-05	2	141	2	10671503
Pubmed	Differential regulation of the zinc finger genes Krox-20 and Krox-24 (Egr-1) suggests antagonistic roles in Schwann cells.	EGR1 EGR2	1.63e-05	2	141	2	9418958
Pubmed	Differential induction of Egr-1 expression in WEHI-231 sublines does not correlate with apoptosis.	EGR1 EGR2	1.63e-05	2	141	2	8344366
Pubmed	A novel form of the RelA nuclear factor kappaB subunit is induced by and forms a complex with the proto-oncogene c-Myc.	MYC RELA	1.63e-05	2	141	2	12027803
Pubmed	An RNA binding protein promotes axonal integrity in peripheral neurons by destabilizing REST.	REST ZFP36L2	1.63e-05	2	141	2	25505318
Pubmed	EGR1 regulates hepatic clock gene amplitude by activating Per1 transcription.	PER1 EGR1	1.63e-05	2	141	2	26471974
Pubmed	Elevated and sustained expression of the transcription factors Egr1 and Egr2 controls NKT lineage differentiation in response to TCR signaling.	EGR1 EGR2	1.63e-05	2	141	2	22306690
Pubmed	Constitutive and inducible levels of egr-1 and c-myc early growth response gene expression in self-renewing B-1 lymphocytes.	MYC EGR1	1.63e-05	2	141	2	7743559
Pubmed	KMT2C/D COMPASS complex-associated diseases [KCDCOM-ADs]: an emerging class of congenital regulopathies.	KMT2C KMT2D	1.63e-05	2	141	2	31924266
Pubmed	Histone H3K4 monomethylation catalyzed by Trr and mammalian COMPASS-like proteins at enhancers is dispensable for development and viability.	KMT2C KMT2D	1.63e-05	2	141	2	28967912
Pubmed	A family of RS domain proteins with novel subcellular localization and trafficking.	RBM26 RBM27	1.63e-05	2	141	2	15741184
Pubmed	Egr-1 abrogates the block imparted by c-Myc on terminal M1 myeloid differentiation.	MYC EGR1	1.63e-05	2	141	2	15840692
Pubmed	Early Growth Response Genes Increases Rapidly After Mechanical Overloading and Unloading in Tendon Constructs.	EGR1 EGR2	1.63e-05	2	141	2	31692087
Pubmed	TET3 is recruited by REST for context-specific hydroxymethylation and induction of gene expression.	REST TET3	1.63e-05	2	141	2	25843715
Pubmed	Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation.	MYC REST	1.63e-05	2	141	2	16478988
Pubmed	Plk4 trans-autophosphorylation regulates centriole number by controlling betaTrCP-mediated degradation.	PLK4 BTRC	1.63e-05	2	141	2	20516151
Pubmed	Association of KMT2C/D loss-of-function variants with response to immune checkpoint blockades in colorectal cancer.	KMT2C KMT2D	1.63e-05	2	141	2	36601880
Pubmed	Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation.	KMT2C KMT2D	1.63e-05	2	141	2	28483418
Pubmed	CRMP1 and CRMP4 are required for proper orientation of dendrites of cerebral pyramidal neurons in the developing mouse brain.	DPYSL3 CRMP1	1.63e-05	2	141	2	27836492
Pubmed	Axonal morphogenesis controlled by antagonistic roles of two CRMP subtypes in microtubule organization.	DPYSL3 CRMP1	1.63e-05	2	141	2	12814366
Pubmed	The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape.	KMT2C KMT2D	1.63e-05	2	141	2	34156443
Pubmed	SCYL1 does not regulate REST expression and turnover.	SCYL1 REST	1.63e-05	2	141	2	28570664
Pubmed	Neurofibromas in NF1: Schwann cell origin and role of tumor environment.	NF1 EGR2	1.63e-05	2	141	2	11988578
Pubmed	Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma.	KMT2C KMT2D	1.63e-05	2	141	2	27280393
Pubmed	EGR2 is critical for peripheral naïve T-cell differentiation and the T-cell response to influenza.	EGR1 EGR2	1.63e-05	2	141	2	25368162
Pubmed	Loss of MLL3/4 decouples enhancer H3K4 monomethylation, H3K27 acetylation, and gene activation during embryonic stem cell differentiation.	KMT2C KMT2D	1.63e-05	2	141	2	36869380
Pubmed	Induction of mPer1 expression by GnRH in pituitary gonadotrope cells involves EGR-1.	PER1 EGR1	1.63e-05	2	141	2	19616057
Pubmed	Macrophage TCF-4 co-activates p65 to potentiate chronic inflammation and insulin resistance in mice.	TCF4 RELA	1.63e-05	2	141	2	27129186
Pubmed	Protein stabilization of ITF2 by NF-κB prevents colitis-associated cancer development.	TCF4 RELA	1.63e-05	2	141	2	37185280
Pubmed	Crucial roles of mixed-lineage leukemia 3 and 4 as epigenetic switches of the hepatic circadian clock controlling bile acid homeostasis in mice.	KMT2C KMT2D	1.63e-05	2	141	2	25346535
Pubmed	The transcription factors Egr1 and Egr2 have opposing influences on adipocyte differentiation.	EGR1 EGR2	1.63e-05	2	141	2	19229250
Pubmed	NF1 loss disrupts Schwann cell-axonal interactions: a novel role for semaphorin 4F.	SEMA4F NF1	1.63e-05	2	141	2	19056885
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	PI4K2A DIDO1 REST MED1 SF1 ABLIM1 KMT2D NF1 FAM13A ZC3H4 RBM14 KAT6B ZNF687	1.72e-05	774	141	13	15302935
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	MYC DIDO1 REST MED1 SF1 DOCK5 PHF2 KMT2C KMT2D LIN37 RBM27 RBM14 RPRD2 ELF4 TET3 ZNF687 FOXC1	2.07e-05	1294	141	17	30804502
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	ARHGAP32 PDLIM7 ZDHHC5 SCYL1 CC2D1A ABLIM1 TJP1 WASF2 PALM3 RELL1 ADGRL2	2.07e-05	565	141	11	25468996
Pubmed	Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins.	KMT2C KMT2D NCOA1	2.30e-05	14	141	3	12482968
Pubmed	Analysis of early C2C12 myogenesis identifies stably and differentially expressed transcriptional regulators whose knock-down inhibits myoblast differentiation.	MYC HIVEP3 EGR1 EGR2	2.33e-05	41	141	4	22147266
Pubmed	Impact of WIN site inhibitor on the WDR5 interactome.	MYC SETD1A KMT2C KMT2D	2.83e-05	43	141	4	33472061
Pubmed	Extensive proteomic screening identifies the obesity-related NYGGF4 protein as a novel LRP1-interactor, showing reduced expression in early Alzheimer's disease.	MAPK8IP1 CC2D1A LRP1	2.86e-05	15	141	3	20205790
Pubmed	Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action.	MAP2 MED1 NCOA1	3.51e-05	16	141	3	10882104
Pubmed	H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation.	SETD1A KMT2C KMT2D	3.51e-05	16	141	3	24368734
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MIER2 TANC2 ARHGAP32 ZDHHC5 PER1 MYORG HIVEP3 PHF2 LDB3 FAT2	3.53e-05	493	141	10	15368895
Pubmed	A High-Density Map for Navigating the Human Polycomb Complexome.	MYC SETD1A PSMB4 FBXL17 DIDO1 KMT2C KMT2D LIN37 RBM14 BTRC	3.65e-05	495	141	10	27705803
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	TCF4 SF1 AMOT RBM14 NCOA1 PLK4	3.81e-05	152	141	6	38360978
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	PDCD6IP RBM27 KIAA1328 ARRDC3 PCDH10 ZNF687	3.95e-05	153	141	6	10718198
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	ARHGAP32 FXR2 PDLIM7 NTAQ1 DEPP1 DVL2 SCYL1 ATXN1 RBM14 TSC22D4 KAT6B	4.04e-05	608	141	11	16713569
Pubmed	Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism.	MIER2 TCF4 FXR2 PDLIM7 PER1 CRMP1 AMOT TSC22D4 PCDH10	4.12e-05	402	141	9	24722188
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	FXR2 PDLIM7 SPART CC2D1A MED1 SF1 FAM193A RBM27 TJP1 ZC3H4 AMOT RBM14	4.18e-05	724	141	12	36232890
Pubmed	A genome-wide meta-analysis of association studies of Cloninger's Temperament Scales.	SLA EGR2 ADGRL2	4.25e-05	17	141	3	22832960
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	SLAIN2 RBM26 DIDO1 CC2D1A MED1 SF1 PHF2 KMT2C KMT2D LIN37 EGR1 RBM27 RBM14 NCOA1 ZNF687	4.44e-05	1103	141	15	34189442
Pubmed	PLK4 deubiquitination by Spata2-CYLD suppresses NEK7-mediated NLRP3 inflammasome activation at the centrosome.	PDLIM7 CC2D1A AMOT PLK4	4.76e-05	49	141	4	31762063
Pubmed	WWP2-WWP1 ubiquitin ligase complex coordinated by PPM1G maintains the balance between cellular p73 and ΔNp73 levels.	PDLIM7 DVL2 SPART AMOT RBM14	4.87e-05	97	141	5	25071155
Pubmed	A family of heptahelical receptors with adhesion-like domains: a marriage between two super families.	ADGRL1 ADGRL2	4.88e-05	3	141	2	10994649
Pubmed	Cells of origin in the embryonic nerve roots for NF1-associated plexiform neurofibroma.	NF1 EGR2	4.88e-05	3	141	2	25446898
Pubmed	Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640.	MYC SPHK2	4.88e-05	3	141	2	27517489
Interaction	NCOA6 interactions	SETD1A RELA MED1 SF1 KMT2C KMT2D EGR2 RBM14 NCOA1 FEV	6.57e-08	145	139	10	int:NCOA6
Interaction	YAP1 interactions	MYC SETD1A DPYSL3 MAP2 PDLIM7 BEAN1 PSMB4 RBM26 DIDO1 CC2D1A RELA MED1 KMT2C ABLIM1 KMT2D NF1 TJP1 AMOT RBM14 RPRD2 FEV ARRDC3 PIP4P2 BTRC FOXC1	1.15e-07	1095	139	25	int:YAP1
Interaction	YWHAH interactions	TANC2 SLAIN2 ARHGAP32 DPYSL3 PDCD6IP MAP2 FXR2 HECTD4 CC2D1A MED1 MAST2 ABLIM1 NF1 FAM13A ATXN1 ZFP36L2 TJP1 AMOT WASF2 CNKSR3 RBM14 NCOA1 TSC22D4 PLK4 KLC3	1.29e-07	1102	139	25	int:YWHAH
Interaction	CXXC1 interactions	MYC SETD1A RELA KMT2C KMT2D ELF4 FEV TET3 PRKY	3.37e-07	132	139	9	int:CXXC1
Interaction	PIN1 interactions	MYC TCF4 PDLIM7 SCYL1 DIDO1 RELA REST MED1 SF1 ZNF783 EGR1 TJP1 AMOT TSC22D4	4.32e-07	383	139	14	int:PIN1
Interaction	NEDD4 interactions	C15orf62 MAPK8IP1 SYNPO2 PDCD6IP MAP2 PDLIM7 BEAN1 DVL2 ZFP36L2 EGR1 AMOT RBM14 SCNN1B ARRDC3 PIP4P2 BTRC	1.13e-06	544	139	16	int:NEDD4
Interaction	ITCH interactions	MYC PDCD6IP MAP2 DVL2 SPART STAM SF1 AMOT RBM14 SCNN1B NCOA1 ARRDC3 PIP4P2	1.15e-06	356	139	13	int:ITCH
Interaction	YWHAG interactions	MYC TANC2 SLAIN2 ARHGAP32 DPYSL3 SYNPO2 PDCD6IP MAP2 HECTD4 DVL2 MAST2 ABLIM1 NF1 FAM13A ATXN1 ZFP36L2 TJP1 AMOT WASF2 CNKSR3 RBM14 TSC22D4 PLK4 BTRC KLC3	1.30e-06	1248	139	25	int:YWHAG
Interaction	YWHAB interactions	MYC TANC2 SLAIN2 ARHGAP32 MAP2 HECTD4 DVL2 STAM MAST2 ABLIM1 NF1 FAM13A ATXN1 ZFP36L2 TJP1 AMOT WASF2 CNKSR3 RBM14 PLK4 BTRC KLC3	1.71e-06	1014	139	22	int:YWHAB
Interaction	TLE3 interactions	MYC TCF4 STAM KMT2D FAM193A ATXN1 EGR1 EGR2 NR5A2 RBM14 NCOA1 FEV FOXC1	2.11e-06	376	139	13	int:TLE3
Interaction	YWHAQ interactions	MYC TANC2 ARHGAP32 MAP2 HECTD4 DVL2 MED1 MAST2 ABLIM1 NF1 FAM13A ATXN1 ZFP36L2 TJP1 WASF2 CNKSR3 RBM14 NCOA1 ARRDC3 PLK4 BTRC KLC3	8.19e-06	1118	139	22	int:YWHAQ
Interaction	SORCS3 interactions	SF1 ATXN1 PLK4	1.10e-05	7	139	3	int:SORCS3
Interaction	WWP1 interactions	PDLIM7 DVL2 PI4K2A SPART DIDO1 HIVEP3 EGR1 AMOT RBM14 ARRDC3	1.33e-05	260	139	10	int:WWP1
Interaction	TOP3B interactions	TANC2 SEMA4F SETD1A SPHK2 PDCD6IP FXR2 HECTD4 DVL2 ZDHHC5 PER1 ADGRL1 CC2D1A GRID1 ATG2A MAST2 ATP13A2 MYORG HIVEP3 KMT2C KMT2D ZFP36L2 RBM14 MYRF PRRT4 ZNF687	2.27e-05	1470	139	25	int:TOP3B
Interaction	PAGR1 interactions	MYC KMT2C KMT2D EGR2 NCOA1	2.64e-05	51	139	5	int:PAGR1
Interaction	FOXK2 interactions	MYC TANC2 RBM26 DVL2 PER1 REST KMT2D AMOT PRKY	2.68e-05	225	139	9	int:FOXK2
Interaction	EP300 interactions	MYC SETD1A TCF4 RBM26 DVL2 SERTAD2 SCYL1 SPART HIC2 RELA MED1 SF1 KMT2D EGR1 RBM27 EGR2 ZC3H4 AMOT RBM14 NCOA1 FEV TMC5 BTRC FOXC1	3.02e-05	1401	139	24	int:EP300
Interaction	KMT2B interactions	MYC SETD1A KMT2C KMT2D ATXN1 ELF4 FEV	3.33e-05	130	139	7	int:KMT2B
Interaction	WWTR1 interactions	SLAIN2 PDLIM7 DVL2 DIDO1 ABLIM1 KMT2D RBM27 TJP1 AMOT RPRD2 ARRDC3 BTRC	3.69e-05	422	139	12	int:WWTR1
Interaction	PARD3 interactions	MYC ARHGAP32 PDLIM7 DVL2 ZDHHC5 CC2D1A TJP1 AMOT ARRDC3 ADGRL2	4.27e-05	298	139	10	int:PARD3
Interaction	ATN1 interactions	SETD1A PDCD6IP FXR2 DVL2 KMT2C EGR2 RBM14 KAT6B	4.73e-05	187	139	8	int:ATN1
Interaction	RAD54L2 interactions	FXR2 ATXN1 EGR2 NR5A2 FEV PRKY	5.07e-05	95	139	6	int:RAD54L2
Interaction	AR interactions	MYC TCF4 PSMB4 HECTD4 RBM26 BLNK DIDO1 RELA MED1 RNF14 KMT2C KMT2D ATXN1 RBM27 TJP1 ZC3H4 RBM14 NCOA1 RPRD2	5.22e-05	992	139	19	int:AR
Interaction	STIL interactions	ARHGAP32 DVL2 CC2D1A DOCK5 ABLIM1 FAM193A PLK4 BTRC	5.29e-05	190	139	8	int:STIL
Interaction	NCOA2 interactions	CC2D1A SLA EGR2 NR5A2 NCOA1 FEV PRKY	5.59e-05	141	139	7	int:NCOA2
Interaction	FAM168A interactions	MYC DVL2 SF1 ATXN1 TJP1 AMOT BTRC	5.85e-05	142	139	7	int:FAM168A
Interaction	FOXP4 interactions	HIC2 EGR2 FEV PRKY ZNF687 FOXC1	6.04e-05	98	139	6	int:FOXP4
Interaction	WWP2 interactions	MYC DPYSL3 PDCD6IP FXR2 PDLIM7 DVL2 SPART DIDO1 STAM SF1 EGR2 TJP1 AMOT WASF2 RBM14 SCNN1B ARRDC3	6.85e-05	840	139	17	int:WWP2
Interaction	SMG7 interactions	FXR2 PSMB4 KMT2D FAM193A ZC3H4 AMOT NCOA1 RPRD2 PRKY BTRC	7.54e-05	319	139	10	int:SMG7
Interaction	FEV interactions	SETD1A PSMB4 HIC2 KMT2C KMT2D ATXN1 FEV FOXC1	8.42e-05	203	139	8	int:FEV
Interaction	TTLL6 interactions	DPYSL3 DVL2 CRMP1	8.73e-05	13	139	3	int:TTLL6
Interaction	POLR2A interactions	MYC SETD1A DPYSL3 DIDO1 RELA MED1 CRMP1 KMT2D NF1 ZC3H4 RPRD2 ARRDC3 BTRC	8.85e-05	536	139	13	int:POLR2A
Interaction	SFN interactions	MYC TANC2 SETD1A ARHGAP32 MAP2 NTAQ1 MAST2 ABLIM1 FAM13A ATXN1 ZFP36L2 TJP1 AMOT RBM14 PLK4	8.86e-05	692	139	15	int:SFN
Interaction	MIF interactions	MYC PDCD6IP NTAQ1 HIC2 NF1 ZFP36L2 ZC3H4 RBM14 RPRD2	9.23e-05	264	139	9	int:MIF
Interaction	ZYX interactions	CASS4 TANC2 ARHGAP32 PDLIM7 SPART ARHGAP9 ABLIM1 ATXN1 TJP1 AMOT	9.73e-05	329	139	10	int:ZYX
Interaction	CSNK2B interactions	MYC FXR2 NTAQ1 DVL2 PER1 FBXL17 DIDO1 PHF2 ATXN1 TJP1 ZC3H4 SPSB3 BTRC ZNF687	1.09e-04	625	139	14	int:CSNK2B
Interaction	ZHX2 interactions	RELA DOCK5 ATXN1 ELF4 FEV	1.15e-04	69	139	5	int:ZHX2
Interaction	CTBP1 interactions	MYC TCF4 NTAQ1 HIC2 MED1 SF1 CREB5 ZNF750 ATXN1 RBM14 FOXC1	1.21e-04	406	139	11	int:CTBP1
Interaction	FOXP2 interactions	HIC2 EGR2 FEV ZNF687 FOXC1	1.23e-04	70	139	5	int:FOXP2
Interaction	SFPQ interactions	MYC FXR2 PER1 DIDO1 REST SF1 ATXN1 ZFP36L2 RBM27 TJP1 RBM14 BTRC FOXC1	1.44e-04	563	139	13	int:SFPQ
Interaction	GPATCH8 interactions	MYC DVL2 ATXN1 FEV ARRDC3 BTRC	1.47e-04	115	139	6	int:GPATCH8
Interaction	SUZ12 interactions	MYC SETD1A PDCD6IP FXR2 RELA REST SF1 PHF2 ABLIM1 KMT2D LIN37 NF1 RBM14 BTRC	1.49e-04	644	139	14	int:SUZ12
Interaction	CTNNA1 interactions	MYC ARHGAP32 PDLIM7 RBM26 ABLIM1 ZFP36L2 EGR2 TJP1 CTDSPL BTRC	1.50e-04	347	139	10	int:CTNNA1
Interaction	AXIN1 interactions	MYC FXR2 NTAQ1 DVL2 SCYL1 CRMP1 BTRC	1.56e-04	166	139	7	int:AXIN1
Interaction	LHX4 interactions	TCF4 KMT2C KMT2D ATXN1 WASF2 TSC22D4 ZNF687	1.56e-04	166	139	7	int:LHX4
Interaction	CAMK2D interactions	MYC SETD1A FXR2 DIDO1 ZNF750 NF1 ARRDC3 PLK4	1.56e-04	222	139	8	int:CAMK2D
Interaction	SETD1B interactions	MYC SETD1A RBM26 KMT2C KMT2D	1.70e-04	75	139	5	int:SETD1B
Interaction	KMT2D interactions	SETD1A RELA KMT2C KMT2D EGR2 ELF4 FEV	1.74e-04	169	139	7	int:KMT2D
Interaction	RNF43 interactions	ARHGAP32 FXR2 PDLIM7 DVL2 ZDHHC5 STAM ABLIM1 FAM193A TJP1 AMOT RBM14	1.87e-04	427	139	11	int:RNF43
Interaction	CTNNB1 interactions	MYC TANC2 TCF4 ARHGAP32 PDCD6IP PDLIM7 DVL2 RELA RNF14 KMT2D FAM193A EGR1 EGR2 TJP1 AMOT NR5A2 RBM14 BTRC	2.03e-04	1009	139	18	int:CTNNB1
Interaction	VDR interactions	MYC NTAQ1 RELA MED1 RNF14 NCOA1	2.52e-04	127	139	6	int:VDR
Interaction	MEN1 interactions	MYC SETD1A FXR2 RBM26 SCYL1 DIDO1 RELA MED1 SF1 KMT2C KMT2D ZFP36L2 TJP1 ZC3H4 RBM14 KAT6B ZNF687 FOXC1	2.57e-04	1029	139	18	int:MEN1
Interaction	PPARGC1A interactions	RELA MED1 SF1 NR5A2 NCOA1	2.59e-04	82	139	5	int:PPARGC1A
Interaction	YWHAZ interactions	MYC TANC2 ARHGAP32 SYNPO2 MAP2 HECTD4 RBM26 MAST2 ABLIM1 NF1 FAM13A ATXN1 ZFP36L2 RBM27 TJP1 CNKSR3 RBM14 TSC22D4 PLK4 BTRC KLC3	2.77e-04	1319	139	21	int:YWHAZ
Interaction	BCO1 interactions	DVL2 ABLIM1	2.81e-04	4	139	2	int:BCO1
Interaction	SIX4 interactions	NTAQ1 EGR2 FEV PRKY	2.82e-04	46	139	4	int:SIX4
Interaction	CAPN13 interactions	DIDO1 SF1 ZC3H4	2.87e-04	19	139	3	int:CAPN13
Interaction	DLG4 interactions	TANC2 SEMA4F ARHGAP32 ZDHHC5 ADGRL1 GRID1 ABLIM1 CNKSR3 LRP1 FRMPD3 PCDH10	2.88e-04	449	139	11	int:DLG4
Cytoband	11q13	BEST1 SCYL1 RELA SF1 KCNK4	3.37e-05	118	141	5	11q13
Cytoband	2p13.1	SEMA4F DQX1 TET3	1.58e-04	34	141	3	2p13.1
Cytoband	17p13.1	SPEM2 FXR2 DVL2 PER1	4.99e-04	118	141	4	17p13.1
Cytoband	Ensembl 112 genes in cytogenetic band chr11q13	TPCN2 SCYL1 RELA ATG2A SF1 KCNK4 RBM14	5.35e-04	454	141	7	chr11q13
GeneFamily	PDZ domain containing	SYNPO2 PDLIM7 DVL2 MAST2 LDB3 TJP1 CNKSR3 FRMPD3	9.77e-07	152	91	8	1220
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	SETD1A KMT2C PRDM8 KMT2D	2.48e-05	34	91	4	487
GeneFamily	PHD finger proteins	DIDO1 PHF2 KMT2C KMT2D KAT6B	9.07e-05	90	91	5	88
GeneFamily	Adhesion G protein-coupled receptors, subfamily L	ADGRL1 ADGRL2	1.49e-04	4	91	2	918
GeneFamily	Zinc fingers CCCH-type	RBM26 RBM27 ZC3H4	7.18e-04	35	91	3	73
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP32 ARHGAP9 FAM13A	2.04e-03	50	91	3	721
GeneFamily	Basic helix-loop-helix proteins	MYC TCF4 ASCL3 NCOA1	2.31e-03	110	91	4	420
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	NCOA1 KAT6B	3.24e-03	17	91	2	486
GeneFamily	LIM domain containing	PDLIM7 ABLIM1 LDB3	3.27e-03	59	91	3	1218
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HRGL2A	TCF4 PER1 REST CREB5 MYORG PRDM8 FAT2 ATXN1 ZFP36L2 EGR1 EGR2 SEL1L3 LRP1 TSC22D4	4.31e-06	600	140	14	M39055
Coexpression	GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN	SETD1A SPHK2 ADGRL1 ATG2A PHF2 KMT2D TMEM44	1.01e-05	139	140	7	M8948
Coexpression	GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_DN	SGMS2 TPCN2 PDLIM7 SPART F5 ATXN1 EGR2 NCOA1	1.13e-05	197	140	8	M8755
Coexpression	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1	ZDHHC5 EGR2 ADGRL2 PCDH10 FOXC1	1.61e-05	59	140	5	MM528
Coexpression	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1	ZDHHC5 EGR2 ADGRL2 PCDH10 FOXC1	1.61e-05	59	140	5	M1238
Coexpression	MURARO_PANCREAS_PANCREATIC_POLYPEPTIDE_CELL	DPYSL3 SYNPO2 MAP2 EGR1 EGR2 FEV ADGRL2	1.89e-05	153	140	7	M39171
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HENDO	MYC TCF4 PER1 REST CREB5 MYORG ABLIM1 ZFP36L2 EGR1 EGR2 TJP1 WASF2 SEL1L3 RELL1 ADGRL2 FOXC1	2.23e-05	888	140	16	M39049
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HRGL2B	TCF4 REST CREB5 MYORG FAT2 ZFP36L2 EGR1 EGR2 SEL1L3 LRP1 TSC22D4	2.51e-05	439	140	11	M39054
Coexpression	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	SLAIN2 ARHGAP32 PDCD6IP PI4K2A GRID1 MAST2 ATP13A2 CRMP1 HIVEP3 LDB3 FAM193A RELL1 KAT6B CTDSPL BTRC	2.86e-05	807	140	15	M14594
Coexpression	PEART_HDAC_PROLIFERATION_CLUSTER_DN	MYC BEST1 NF1 RBM14 PLK4	3.97e-05	71	140	5	M1421
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	SLAIN2 PSMB4 HECTD4 RBM26 SERTAD2 ARHGAP9 REST MED1 SLA SF1 HIVEP3 KMT2C KMT2D ATXN1 ZFP36L2 RBM27 SEL1L3 NCOA1 TSC22D4 KAT6B PRKY	4.45e-05	1492	140	21	M40023
Coexpression	WNT_UP.V1_UP	MAPK8IP1 LCAT MAST2 KCNK4 CRMP1 NF1 MYRF	4.63e-05	176	140	7	M2690
Coexpression	GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_UP	PDLIM7 STAM RNF14 ABLIM1 EGR1 EGR2 NCOA1	4.80e-05	177	140	7	M8177
Coexpression	PRC2_SUZ12_UP.V1_UP	STAB2 REST LCAT FAT2 ATXN1 TET3 PRKY	6.35e-05	185	140	7	M2741
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN	CASS4 SLAIN2 TPCN2 RBM26 PI4K2A PER1 HIC2 RELA STAM ATXN1 RBM27 NCOA1 RELL1	7.56e-05	680	140	13	M41089
Coexpression	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	MYC DIDO1 EGR1 CNKSR3 ARRDC3	8.41e-05	83	140	5	M15537
Coexpression	GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP	TANC2 ARHGAP32 RBM26 KMT2C ABLIM1 RBM27 RPRD2	8.56e-05	194	140	7	M3321
Coexpression	AIZARANI_LIVER_C21_STELLATE_CELLS_1	MYC TCF4 SYNPO2 DEPP1 EGR1 LRP1 CTDSPL	8.56e-05	194	140	7	M39122
Coexpression	GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP	TANC2 HECTD4 ABLIM1 NF1 ZNF394 ZFP36L2 SPSB3	8.83e-05	195	140	7	M7397
Coexpression	GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP	ATG2A ABLIM1 ZNF394 AMOT NCOA1 PRKY SPSB3	9.12e-05	196	140	7	M4532
Coexpression	GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN	PDCD6IP DIDO1 RBM27 TMEM44 CNKSR3 NCOA1 BTRC	9.72e-05	198	140	7	M9346
Coexpression	GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_DN	SGMS2 SCYL1 STAM F5 ATXN1 EGR2 CTDSPL	9.72e-05	198	140	7	M8750
Coexpression	GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_UP	DPYSL3 PI4K2A ADGRL1 MYORG LDB3 ELF4 BTRC	1.00e-04	199	140	7	M3599
Coexpression	CAMP_UP.V1_DN	TANC2 DPYSL3 MAP2 ABLIM1 PRDM8 TJP1 SEL1L3	1.00e-04	199	140	7	M2719
Coexpression	GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP	BLNK FAM193A AMOT LRP1 RELL1 TSC22D4 CTDSPL	1.00e-04	199	140	7	M8639
Coexpression	GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN	DVL2 CREB5 HIVEP3 BNC1 PRDM8 EGR1 EGR2	1.00e-04	199	140	7	M9751
Coexpression	GSE3982_MAST_CELL_VS_NKCELL_DN	ARHGAP32 STAB2 DIDO1 ZNF394 NCOA1 TMC5 SPSB3	1.00e-04	199	140	7	M5452
Coexpression	GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP	CASS4 SLC2A8 PI4K2A FBXL17 SLC11A1 WASF2 ADGRL2	1.03e-04	200	140	7	M9485
Coexpression	GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN	MIER2 SETD1A MBOAT7 DVL2 SF1 PHF2 NCOA1	1.03e-04	200	140	7	M5991
Coexpression	GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP	SEMA4F PER1 DIDO1 RELA SF1 SPSB3 BBOF1	1.03e-04	200	140	7	M4590
Coexpression	GSE29618_MONOCYTE_VS_MDC_UP	BEST1 F5 SLC11A1 ATXN1 EGR1 EGR2 LRP1	1.03e-04	200	140	7	M4948
Coexpression	GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN	SPHK2 STAB2 DOCK5 SLC11A1 ATXN1 CNKSR3 LRP1	1.03e-04	200	140	7	M6626
Coexpression	GSE23925_DARK_ZONE_VS_NAIVE_BCELL_DN	MAPK8IP1 FXR2 PER1 ASCL3 SLA EGR1 EGR2	1.03e-04	200	140	7	M7881
Coexpression	GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_UP	SPHK2 PER1 ATP13A2 ZFP36L2 EGR1 EGR2 COQ9	1.03e-04	200	140	7	M4139
Coexpression	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	SYNPO2 MAP2 DEPP1 PER1 SF1 LIN37 EGR1	1.24e-04	206	140	7	M14134
Coexpression	PDGF_ERK_DN.V1_DN	MYC PER1 HIC2 BNC1 ZFP36L2 EGR1	1.53e-04	149	140	6	M2828
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN	SPHK2 HECTD4 DIDO1 ARHGAP9 HIC2 ATG2A SF1 SLC11A1 ZFP36L2 ELF4 ARRDC3 SPSB3	1.58e-04	634	140	12	M40866
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	MYC AVL9 SPART STAM MED1 MAST2 CREB5 FAM193A ATXN1 ZFP36L2 ZC3H4 NCOA1 KAT6B BTRC	2.05e-04	856	140	14	M4500
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	MYC SERTAD2 DIDO1 FAT2 ZC3H4 ADGRL2 KAT6B PLK4	2.17e-04	300	140	8	M8702
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4\|TCGA-Thryoid / Sample_Type by Project: Shred V9	MAP2 SERTAD2 PI4K2A ZDHHC5 STAM BNC1 AMOT KLC3	1.34e-07	184	141	8	d9659d1e4465fec68f48a22edef443f354f6c7cf
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BEST1 MBOAT7 SLA CREB5 DOCK5 SLC11A1 EGR1 PIP4P2	1.78e-07	191	141	8	47156e5f1d790707f42f6283104a44b33af613e5
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BEST1 MBOAT7 PDLIM7 ARHGAP9 SLA CREB5 DOCK5 SLC11A1	2.01e-07	194	141	8	607b5d194ba56efa9b106f10f89368fc103712a0
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BEST1 MBOAT7 PDLIM7 ARHGAP9 SLA CREB5 DOCK5 SLC11A1	2.01e-07	194	141	8	f5367072b259ae170cf0df3d4d871ab41be29d29
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	TCF4 DPYSL3 MAP2 SLA CRMP1 HIVEP3 PRDM8 ARRDC3	2.53e-07	200	141	8	306926cb7a847871641f02e03d52dc56fd55711c
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAP2 MS4A15 ABLIM1 TJP1 SCNN1B TMC5 MYRF	1.69e-06	179	141	7	4f6ca313b78aa93557937a046c44dcf8bcc9963c
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAP2 MS4A15 ABLIM1 TJP1 SCNN1B TMC5 MYRF	2.11e-06	185	141	7	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	Epithelial-alveolar_epithelial_cell_type_1\|World / Lineage, Cell type, age group and donor	MAP2 MS4A15 ABLIM1 TJP1 SCNN1B TMC5 MYRF	2.18e-06	186	141	7	09d95daa3387a4814cffaa4b798cc2810c3759d0
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYC TCF4 DPYSL3 CREB5 EGR1 RBM27 WASF2	2.34e-06	188	141	7	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	MAP2 MS4A15 ABLIM1 TJP1 SCNN1B TMC5 MYRF	2.43e-06	189	141	7	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TCF4 DPYSL3 CREB5 DOCK5 ABLIM1 CNKSR3 NR5A2	2.51e-06	190	141	7	6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TCF4 MAP2 DEPP1 CRMP1 TJP1 TMEM44 ADGRL2	2.51e-06	190	141	7	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	human_hepatoblastoma-Endothelial_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	TANC2 TCF4 DPYSL3 MAP2 CREB5 HIVEP3 ADGRL2	2.51e-06	190	141	7	8d6ef93d69e96cd6921816d152bea3b0710cf147
ToppCell	human_hepatoblastoma-Endothelial_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	TANC2 TCF4 DPYSL3 MAP2 CREB5 HIVEP3 ADGRL2	2.69e-06	192	141	7	e09f609fed033a25baacaf4a07bbbae1076da366
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TCF4 DEPP1 ABLIM1 CNKSR3 NR5A2 ADGRL2 FOXC1	2.79e-06	193	141	7	9ba688b35a9ead5d04691b3f3f15484f02dbbd0d
ToppCell	control-Myeloid-Neutrophils_3\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MBOAT7 PDLIM7 ARHGAP9 F5 CREB5 SLC11A1 EGR1	2.79e-06	193	141	7	56daf3c59a124dd068af5409113913d9ee81a454
ToppCell	IPF-Endothelial\|IPF / Disease state, Lineage and Cell class	TCF4 DPYSL3 DEPP1 ABLIM1 CNKSR3 NR5A2 ADGRL2	2.89e-06	194	141	7	9591993aa2dcba3d09a0f1ea8b8f2439c26482d6
ToppCell	IPF-Endothelial-VE_Peribronchial\|World / Disease state, Lineage and Cell class	TCF4 DPYSL3 DEPP1 ABLIM1 CNKSR3 NR5A2 ADGRL2	2.99e-06	195	141	7	120296531bbc8080dcabacbd64733cc1dc34603a
ToppCell	356C-Epithelial_cells-Epithelial-I_(AT1)\|356C / Donor, Lineage, Cell class and subclass (all cells)	MAP2 MS4A15 ABLIM1 TJP1 SCNN1B CTDSPL MYRF	2.99e-06	195	141	7	07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904
ToppCell	facs-Brain_Myeloid-Hippocampus\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASS4 TANC2 TJP1 WASF2 TMEM44 LRP1 ADGRL2	2.99e-06	195	141	7	a1478021a3ed0e779716393124ca2a7770c433b7
ToppCell	356C-Epithelial_cells-Epithelial-I_(AT1)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	MAP2 MS4A15 ABLIM1 TJP1 SCNN1B CTDSPL MYRF	2.99e-06	195	141	7	b65511770ed67f7447847e2187555b362988af45
ToppCell	Children_(3_yrs)-Endothelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TCF4 DPYSL3 ABLIM1 TMEM44 CNKSR3 NR5A2 ADGRL2	2.99e-06	195	141	7	094cf6591daa5ffad36e44122b6f524a3a34c2fd
ToppCell	control-Myeloid-Neutrophils_1\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CASS4 MBOAT7 PDLIM7 ARHGAP9 CREB5 DOCK5 SLC11A1	3.09e-06	196	141	7	9c8623232c47af5de9f360fd5c5113362e37c6c9
ToppCell	Endothelial\|World / Lineage, Cell type, age group and donor	TCF4 DPYSL3 STAB2 DEPP1 TMEM44 NR5A2 ADGRL2	3.09e-06	196	141	7	96c6d78482a130ce4e29f6629972a06d10d7530e
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAP2 MS4A15 DOCK5 ABLIM1 TJP1 SCNN1B MYRF	3.19e-06	197	141	7	8d5097898dd01cedb04cb694cb480c931e08462c
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BEST1 MBOAT7 PDLIM7 ARHGAP9 SLA CREB5 SLC11A1	3.19e-06	197	141	7	340ce4fef244176fb52e38ffbcbdfda5ac3467dd
ToppCell	distal-Endothelial-Bronchial_Vessel_1-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MYC TCF4 EGR1 CNKSR3 NR5A2 RELL1 FOXC1	3.19e-06	197	141	7	0d1afd1ad7489c071db08b3dfff598423097d7e0
ToppCell	droplet-Heart-HEART-1m-Hematologic-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPCN2 AVL9 BLNK ZNF394 SCIMP ZNF687	3.22e-06	127	141	6	983489a69d3b1f1fe21110a862ac1dba53e9d31c
ToppCell	PBMC-Mild-cDC_0\|Mild / Compartment, Disease Groups and Clusters	PI4K2A F5 SLC11A1 ATXN1 EGR1 LRP1 NCOA1	3.30e-06	198	141	7	fb873b7636bb1c7b119dd5b23d7a20f518e6c6da
ToppCell	distal-1-Endothelial-Bronchial_Vessel_1\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MYC TCF4 EGR1 CNKSR3 NR5A2 RELL1 FOXC1	3.30e-06	198	141	7	5cd81fe1a21c0e1a7f0d5a62ddf8e422b05aedc7
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	TANC2 ARHGAP32 FBXL17 NF1 ATXN1 KIAA1328 NCOA1	3.30e-06	198	141	7	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Caecum-(2)_B_cell-(21)_B_cell_IgG_Plasma\|Caecum / shred on region, Cell_type, and subtype	TCF4 BLNK SCYL1 TJP1 DQX1 SEL1L3 PALM3	3.30e-06	198	141	7	3893fcfc1de5937be3ccc7e545f711f2c95a2827
ToppCell	Caecum-B_cell-B_cell_IgG_Plasma\|Caecum / Region, Cell class and subclass	TCF4 BLNK SCYL1 TJP1 DQX1 SEL1L3 PALM3	3.30e-06	198	141	7	d8cb78b1763710a158cf22b59aebaa44afd2374c
ToppCell	COVID-19_Mild-Classical_Monocyte\|COVID-19_Mild / Disease condition and Cell class	SLA F5 CREB5 SLC11A1 EGR1 LRP1 TET3	3.30e-06	198	141	7	30ada3de865b6fb2b14196a1cbfd4740c6a57ce3
ToppCell	mild-HLA-DR-_S100A+_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MBOAT7 CREB5 DOCK5 SLC11A1 EGR1 EGR2 LRP1	3.41e-06	199	141	7	d0d286eafe935f9b3aaba5b783e8911251121b4a
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	TCF4 DPYSL3 MAP2 SLA CRMP1 HIVEP3 ARRDC3	3.41e-06	199	141	7	a255484ba77bd2741a541da278efc8cf4abbe570
ToppCell	367C-Endothelial_cells-Endothelial-A_(Artery)\|367C / Donor, Lineage, Cell class and subclass (all cells)	TCF4 DEPP1 ABLIM1 CNKSR3 NR5A2 ADGRL2 FOXC1	3.41e-06	199	141	7	29ed081bd5204a32068b420f2244f3704891547b
ToppCell	367C-Endothelial_cells-Endothelial-A_(Artery)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	TCF4 DEPP1 ABLIM1 CNKSR3 NR5A2 ADGRL2 FOXC1	3.41e-06	199	141	7	c2d85f80037f209a4a329790f475d9f98f590262
ToppCell	mild-HLA-DR+_CD83+_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PER1 CREB5 DOCK5 SLC11A1 EGR1 LRP1 TET3	3.53e-06	200	141	7	934c2efc780318c66d667ca75be0de350361d351
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate\|2m / Sample Type, Dataset, Time_group, and Cell type.	TCF4 DPYSL3 MAP2 CREB5 CRMP1 NF1 KAT6B	3.53e-06	200	141	7	2a635694844ddabcd98462c5636a6f41a3f08a46
ToppCell	normal_Lymph_Node-B_lymphocytes-Undetermined\|normal_Lymph_Node / Location, Cell class and cell subclass	TCF4 BLNK ASCL3 SF1 ZFP36L2 SEL1L3	1.30e-05	162	141	6	91ac35ae7fde411cd6a44e715a33dac62419cab8
ToppCell	P28-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DNHD1 MAP2 CC2D1A KMT2C ARRDC3 KLC3	1.60e-05	168	141	6	8c8dbdbc7053f34e4ca0c5067af502fbea109fc1
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SLAIN2 DEPP1 RELA ABLIM1 AMOT CNKSR3	1.71e-05	170	141	6	55fe16d98ea284d05fb899888e4569c685644c7b
ToppCell	droplet-Lung-nan-3m-Myeloid-plasmacytoid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF4 MAP2 BLNK HIVEP3 RELL1 SCIMP	1.89e-05	173	141	6	1b9b4e165121b08ef15a93fca6bea875cae69f19
ToppCell	droplet-Lung-nan-3m-Myeloid-Plasmacytoid_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF4 MAP2 BLNK HIVEP3 RELL1 SCIMP	1.89e-05	173	141	6	c25f24d7b672c9686d31ebc8d263042282f520fd
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	MAP2 MS4A15 ABLIM1 TJP1 SCNN1B MYRF	1.95e-05	174	141	6	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	ASK428-Immune-B_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	LIAS BLNK SEL1L3 SCNN1B TMC5 CTDSPL	2.02e-05	175	141	6	e0979e5795a49b4e5c9b88e7fe6b7bda7a413a6c
ToppCell	Control-Neuronal_cells-Neuronal_cells\|Control / group, cell type (main and fine annotations)	TCF4 DPYSL3 STAB2 CREB5 CNKSR3 NR5A2	2.08e-05	176	141	6	98c07d26ba0dc0fe15ca0ea81f633d4591782bd1
ToppCell	Control-Neuronal_cells\|Control / group, cell type (main and fine annotations)	TCF4 DPYSL3 STAB2 CREB5 CNKSR3 NR5A2	2.08e-05	176	141	6	c29d09ecf0eb17f767d78af4b7f2e7725c967ff8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	F5 DOCK5 TJP1 CTDSPL TMEM200C FOXC1	2.15e-05	177	141	6	4d2cdb57b427a42085c5f9affa0967b15e84dec3
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP2 GRID1 MS4A15 MYORG MYRF KLC3	2.29e-05	179	141	6	d5e3e7f1cd8f683f39a7416f12af7e766dcbead8
ToppCell	COVID-19-Heart-Lymph_EC\|Heart / Disease (COVID-19 only), tissue and cell type	TANC2 STAB2 DOCK5 PRDM8 CNKSR3 SCNN1B	2.29e-05	179	141	6	411620201a860716a8773b92f50f7b94ef34a586
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF4 BLNK ATP13A2 HIVEP3 RELL1 SCIMP	2.36e-05	180	141	6	df60970520fba2ac0639faa54096766d07418ca4
ToppCell	IIH-Treg-proli_CD4\|IIH / Condition, Cell_class and T cell subcluster	ATP13A2 PHF2 NAA35 COQ9 ELF4 BTRC	2.52e-05	182	141	6	5c7d02da9ca2bca49db9832704b6894dfaa08a71
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 STAB2 DEPP1 DOCK5 HIVEP3 TMEM44	2.52e-05	182	141	6	41b070085edba7a58b81c20aa4942d06f745acf8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 STAB2 DEPP1 DOCK5 HIVEP3 TMEM44	2.52e-05	182	141	6	5e9a67b2de0daa4fdc344b10a857d8a901ad810e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 STAB2 DEPP1 DOCK5 HIVEP3 TMEM44	2.52e-05	182	141	6	b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAP2 F5 DOCK5 TJP1 TMEM200C FOXC1	2.59e-05	183	141	6	848fc6dd129150897ee339343e83c645b6e779eb
ToppCell	COVID-19-lung-AT1\|lung / Disease (COVID-19 only), tissue and cell type	MAP2 MS4A15 ABLIM1 SCNN1B TMC5 MYRF	2.59e-05	183	141	6	942530449e9c6583705eeb8f6f12621daea57252
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BEST1 CREB5 DOCK5 LDB3 TSC22D4 MYRF	2.59e-05	183	141	6	93213124e55d1b673dd345188caf8b5bd31d99fe
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DPYSL3 F5 DOCK5 TJP1 TMEM200C FOXC1	2.59e-05	183	141	6	7c4b775f351794a3de06bd503eecbc8ae8577c44
ToppCell	Control-Endothelial_cells-Pulmonary_venous_endothelial_cells\|Control / group, cell type (main and fine annotations)	TCF4 DEPP1 ABLIM1 CNKSR3 NR5A2 ADGRL2	2.59e-05	183	141	6	46be9f96755c7b65aeac061d95d15abeb6466034
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MAP2 MS4A15 ABLIM1 TJP1 SCNN1B MYRF	2.67e-05	184	141	6	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAP2 MS4A15 ABLIM1 SCNN1B TMC5 MYRF	2.67e-05	184	141	6	29c95b814a0b1ad8734ed68b77df29c08594e5ec
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MAP2 MS4A15 ABLIM1 TJP1 SCNN1B MYRF	2.67e-05	184	141	6	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	mild-Myeloid-Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CASS4 MBOAT7 ATG2A CREB5 DOCK5 NCOA1	2.67e-05	184	141	6	1a0e8b20b3ac8416d05c2d5934ab4ac80be4cce5
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CREB5 DOCK5 LDB3 ZFP36L2 TSC22D4 MYRF	2.76e-05	185	141	6	b5277190866d9eb5b85eceaa5ba116ea6e6f286b
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	F5 DOCK5 TJP1 CTDSPL TMEM200C FOXC1	2.76e-05	185	141	6	9197f074e769d54031ec41abfc65fcc0c6552c7e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	F5 DOCK5 TJP1 CTDSPL TMEM200C FOXC1	2.76e-05	185	141	6	ce7d62394b09c26ca65b8cdb280afec5e25bbb62
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BEST1 CREB5 DOCK5 LDB3 TSC22D4 MYRF	2.84e-05	186	141	6	d57c40b3fe5cfc87e771df76533d9a3e94678b04
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CREB5 KMT2C SLC11A1 EGR1 LRP1 TET3	2.84e-05	186	141	6	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BEST1 CREB5 DOCK5 LDB3 TSC22D4 MYRF	2.84e-05	186	141	6	90eaf6ffb4ce0c34fa1e79f0c8f36f217f44973b
ToppCell	Control-Epithelial-Club\|World / Disease state, Lineage and Cell class	MS4A15 TJP1 CNKSR3 SCNN1B PALM3 TMC5	2.84e-05	186	141	6	9798428691408e17ff2af2fe2d1b345f074d67e4
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BEST1 CREB5 DOCK5 LDB3 TSC22D4 MYRF	2.84e-05	186	141	6	bd8a9753df219084e19e7f94447856e86608325c
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAP2 MS4A15 ABLIM1 TJP1 SCNN1B MYRF	2.93e-05	187	141	6	d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|368C / Donor, Lineage, Cell class and subclass (all cells)	MS4A15 KIAA1328 SCNN1B PALM3 TMC5 ZNF687	2.93e-05	187	141	6	b827d9da7032bf051756ddf88352af922eb0f87b
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 SGMS2 BEAN1 BLNK HIVEP3 ADGRL2	2.93e-05	187	141	6	77886f99c229610abd28c4c370d2c7d1536c9782
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	MS4A15 KIAA1328 SCNN1B PALM3 TMC5 ZNF687	2.93e-05	187	141	6	61c00604dda8b36a5c3eea6554e5601aa1b884f7
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	MAP2 MS4A15 ABLIM1 TJP1 SCNN1B MYRF	2.93e-05	187	141	6	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DPYSL3 SYNPO2 MAP2 PDLIM7 GRID1 LDB3	3.02e-05	188	141	6	b2d68a32314e9b099ed74d974079ad96359d1ae3
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TCF4 DEPP1 TMEM44 CNKSR3 NR5A2 ADGRL2	3.02e-05	188	141	6	117dc80fa940e6aa1b0187a43fdde33f3fcb578f
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CREB5 DOCK5 LDB3 CNKSR3 TSC22D4 MYRF	3.02e-05	188	141	6	b04fd6a724c117eb9a979c29b91f90113feb7a5c
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TCF4 BLNK SEL1L3 SCNN1B SCIMP SERPINA9	3.02e-05	188	141	6	c3cae529fdbeb233d2b32bcc3537a8aba26a7dc2
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BEST1 CREB5 DOCK5 LDB3 TSC22D4 MYRF	3.02e-05	188	141	6	d9692b6048d9b85524a07a1807bdd4757731c151
ToppCell	Control-Endothelial-VE_Venous\|World / Disease state, Lineage and Cell class	TCF4 DEPP1 ABLIM1 CNKSR3 ADGRL2 FOXC1	3.11e-05	189	141	6	f83f7521e377ded1522639e9a35c98b3e2725bac
ToppCell	P03-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MYC PDLIM7 CREB5 LDB3 SLC11A1 FOXC1	3.11e-05	189	141	6	b5439ef221106f6d54434f268485e9bb17b39102
ToppCell	COVID-19-Endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	TCF4 ABLIM1 TJP1 CNKSR3 NR5A2 ADGRL2	3.20e-05	190	141	6	9fbd92cd6d4683b2490504d29c43cf42020433d4
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BEST1 CREB5 DOCK5 LDB3 TSC22D4 MYRF	3.20e-05	190	141	6	396b7225c2430db3dc55a3d0db70239b71987229
ToppCell	Endothelial-A-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	TCF4 DPYSL3 DEPP1 NR5A2 ADGRL2 FOXC1	3.30e-05	191	141	6	f702dfe88a9b04091dae87df61b2b4f43525f86a
ToppCell	5'-Adult-LymphNode-Epithelial-goblet-BEST2+_Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AVL9 SERTAD2 STAM MYORG LIN37 SCIMP	3.30e-05	191	141	6	e5c41c3054ead03597c136eaccaf9822e6bb9d1a
ToppCell	5'-Adult-LymphNode-Epithelial-goblet\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AVL9 SERTAD2 STAM MYORG LIN37 SCIMP	3.30e-05	191	141	6	7e24175c7fabe5ea0b22b73173da4c3a666e5eb8
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TCF4 DEPP1 CNKSR3 NR5A2 RELL1 ADGRL2	3.30e-05	191	141	6	a7b18bcf27c38ad2353c239ecb309c80f3ef3359
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BEST1 CREB5 DOCK5 LDB3 TSC22D4 MYRF	3.30e-05	191	141	6	2110a1dd10730ad7ee7a265fb1716ab3ddafcf4a
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CREB5 DOCK5 LDB3 ZFP36L2 TSC22D4 MYRF	3.30e-05	191	141	6	2b056cbe2e82e056e1f798974999378460eb1d16
ToppCell	NS-moderate-d_16-33-Myeloid-Neutrophil\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	BEST1 MBOAT7 SLA CREB5 SLC11A1 EGR1	3.39e-05	192	141	6	545c3990cbe3c04bfd95a0ab7499d2c4af509be1
ToppCell	moderate-Myeloid-Neutrophil\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	BEST1 MBOAT7 SLA CREB5 SLC11A1 EGR1	3.39e-05	192	141	6	8105408400dac5dcb0ce62b558433257559c9f09
ToppCell	facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAPK8IP1 SGMS2 SPART ATP13A2 CREB5 FOXC1	3.49e-05	193	141	6	eba3c70701b051bc1ed1f4db9270cb27a77ffc3e
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_1\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ZDHHC5 DOCK5 ZNF750 RBM27 AIFM3 TMC5	3.49e-05	193	141	6	0ef076417ffe2dd1cbc2c3d1e35c7f8522af143b
ToppCell	COPD-Endothelial\|COPD / Disease state, Lineage and Cell class	TCF4 DPYSL3 DEPP1 ABLIM1 CNKSR3 ADGRL2	3.49e-05	193	141	6	093b28dcccb5841c995d0b33fae0efd6b88f97e0
ToppCell	IPF-Endothelial-VE_Venous\|IPF / Disease state, Lineage and Cell class	TCF4 DEPP1 ABLIM1 CNKSR3 NR5A2 ADGRL2	3.49e-05	193	141	6	29a655fa80feaabe846c90a28363b037e22d24ae
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	MYC SPHK2 DIDO1 PHF2 ZFP36L2 ZC3H4 RPRD2 ELF4 KAT6B FOXC1	1.28e-07	174	140	10	5945_DN
Drug	PHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A	SETD1A SPHK2 DPYSL3 DVL2 PHF2 NF1 ZFP36L2 ELF4 CTDSPL BTRC	3.19e-07	192	140	10	4330_DN
Drug	Bethanechol chloride [590-63-6]; Down 200; 20.4uM; MCF7; HT_HG-U133A	SPHK2 AVL9 PDLIM7 PI4K2A MAST2 ZNF750 NF1 ZFP36L2 PLK4 BTRC	4.24e-07	198	140	10	3537_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	MYC DIDO1 PHF2 ZFP36L2 ZC3H4 RPRD2 ELF4 KAT6B FOXC1	1.22e-06	172	140	9	1072_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA	MYC DIDO1 PHF2 ZFP36L2 ZC3H4 RPRD2 ELF4 KAT6B FOXC1	1.41e-06	175	140	9	1058_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	MYC DIDO1 PHF2 ZFP36L2 ZC3H4 RPRD2 ELF4 KAT6B FOXC1	1.86e-06	181	140	9	6951_DN
Drug	Ricinine [524-40-3]; Down 200; 24.4uM; HL60; HT_HG-U133A	RBM26 DVL2 PER1 CC2D1A RELA ZNF783 NF1 FAM13A ZFP36L2	3.16e-06	193	140	9	2505_DN
Drug	Naringenine [480-41-1]; Up 200; 14.6uM; MCF7; HT_HG-U133A	SETD1A SPHK2 PER1 ADGRL1 HIC2 ATG2A SLC11A1 ZFP36L2 CTDSPL	3.44e-06	195	140	9	3278_UP
Drug	Fluticasone propionate [80474-14-2]; Down 200; 8uM; PC3; HT_HG-U133A	TCF4 ARHGAP32 STAB2 FXR2 CC2D1A HIC2 CRMP1 ZFP36L2 BTRC	3.44e-06	195	140	9	4011_DN
Drug	Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A	EPM2A AVL9 PDLIM7 PI4K2A SF1 ZNF750 LDB3 ZFP36L2 EGR1	3.74e-06	197	140	9	3466_UP
Drug	Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	SPHK2 AVL9 DEPP1 F5 ZNF783 CRMP1 NF1 EGR1 ADGRL2	3.74e-06	197	140	9	3786_DN
Drug	Tiaprofenic acid [33005-95-7]; Up 200; 15.4uM; HL60; HT_HG-U133A	SEMA4F SPHK2 PDLIM7 HIC2 ATP13A2 CRMP1 ABLIM1 CTDSPL BTRC	3.89e-06	198	140	9	2492_UP
Drug	Diperodon hydrochloride [537-12-2]; Down 200; 9.2uM; PC3; HT_HG-U133A	SLC2A8 FXR2 PDLIM7 DVL2 HIVEP3 ZFP36L2 LRP1 ELF4 BTRC	3.89e-06	198	140	9	4498_DN
Drug	Noscapine [128-62-1]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ARHGAP32 MBOAT7 FXR2 DVL2 REST ZNF783 ZFP36L2 NCOA1 SPSB3	3.89e-06	198	140	9	7204_DN
Drug	Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A	STAB2 PDLIM7 REST MED1 SF1 NF1 EGR1 PLK4 BTRC	3.89e-06	198	140	9	3292_DN
Drug	Paclitaxel [33069-62-4]; Down 200; 4.6uM; MCF7; HT_HG-U133A	SEMA4F SPHK2 EPM2A MBOAT7 DVL2 ADGRL1 REST PLK4 BTRC	4.06e-06	199	140	9	1542_DN
Drug	Clemizole hydrochloride [1163-36-6]; Down 200; 11uM; MCF7; HT_HG-U133A	EPM2A PDLIM7 DVL2 PI4K2A DOCK5 NF1 ZFP36L2 TMC5 BTRC	4.06e-06	199	140	9	4695_DN
Drug	Bupropion hydrochloride [31677-93-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A	SEMA4F SPHK2 STAB2 AVL9 CC2D1A HIC2 REST EGR1 PLK4	4.06e-06	199	140	9	6256_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	MYC HIVEP3 PHF2 NF1 ZFP36L2 KAT6B PLK4 FOXC1	9.30e-06	167	140	8	3979_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	MYC DIDO1 PHF2 ZFP36L2 ZC3H4 RPRD2 ELF4 KAT6B	1.06e-05	170	140	8	1050_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA	MYC PHF2 ZFP36L2 ZC3H4 RPRD2 ELF4 KAT6B FOXC1	1.11e-05	171	140	8	1000_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	MYC EPM2A DIDO1 PHF2 ZFP36L2 ZC3H4 RPRD2 KAT6B	1.15e-05	172	140	8	5903_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	EPM2A AVL9 DIDO1 PHF2 ZC3H4 RPRD2 TMC5 KAT6B	1.26e-05	174	140	8	3993_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	MYC PHF2 ZFP36L2 ZC3H4 RPRD2 ELF4 KAT6B FOXC1	1.31e-05	175	140	8	7236_DN
Drug	trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA	MYC PHF2 FAM193A ZFP36L2 ZC3H4 ELF4 KAT6B FOXC1	1.36e-05	176	140	8	981_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	MYC DIDO1 PHF2 ZFP36L2 RPRD2 ELF4 KAT6B FOXC1	1.48e-05	178	140	8	992_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A	MYC EPM2A DIDO1 SLA PHF2 ZC3H4 RPRD2 ELF4	1.54e-05	179	140	8	1175_DN
Drug	scriptaid; Down 200; 10uM; MCF7; HT_HG-U133A	MYC ZNF783 PHF2 ZFP36L2 ZC3H4 ELF4 KAT6B FOXC1	1.54e-05	179	140	8	6901_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	MYC DVL2 ATG2A ZFP36L2 RBM14 NCOA1 KAT6B FOXC1	1.88e-05	184	140	8	1064_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	MYC ARHGAP32 MAST2 ATP13A2 ZFP36L2 EGR1 KAT6B FOXC1	2.28e-05	189	140	8	1651_DN
Drug	Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A	TANC2 DPYSL3 FXR2 PI4K2A MED1 ATP13A2 NF1 ZFP36L2	2.28e-05	189	140	8	6649_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A	BEST1 PI4K2A ADGRL1 CRMP1 FAT2 NF1 MYRF BBOF1	2.37e-05	190	140	8	2375_UP
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	TANC2 REST MED1 SF1 CREB5 HIVEP3 ABLIM1 NF1	2.46e-05	191	140	8	4279_DN
Drug	Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; MCF7; HT_HG-U133A	PI4K2A PER1 ZFP36L2 EGR1 NR5A2 LRP1 TSC22D4 BTRC	2.46e-05	191	140	8	4791_UP
Drug	Pinacidil [85371-64-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A	EPM2A PDLIM7 SPART DOCK5 NF1 ZFP36L2 CTDSPL BTRC	2.46e-05	191	140	8	5456_DN
Drug	Chloroprene	CASS4 TCF4 DPYSL3 SYNPO2 BLNK PER1 ARHGAP9 MED1 SLA F5 DOCK5 HIVEP3 BNC1 PRDM8 LDB3 FAM193A FAM13A EGR1 EGR2 WASF2 ARRDC3 SERPINA9	2.55e-05	1348	140	22	ctd:D002737
Drug	15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A	TANC2 EPM2A PDLIM7 DIDO1 CC2D1A NF1 TJP1 ELF4	2.55e-05	192	140	8	6990_DN
Drug	SC 19220; Down 200; 10uM; PC3; HT_HG-U133A	TANC2 TCF4 AVL9 PI4K2A PER1 ADGRL1 ZNF783 PHF2	2.55e-05	192	140	8	7065_DN
Drug	pararosaniline base; Down 200; 10uM; MCF7; HT_HG-U133A_EA	EPM2A MBOAT7 DVL2 ZFP36L2 RBM14 CTDSPL SPSB3 FOXC1	2.65e-05	193	140	8	893_DN
Drug	(-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A	STAB2 HIC2 REST DOCK5 NF1 EGR1 ELF4 KAT6B	2.75e-05	194	140	8	4134_DN
Drug	Harmalol hydrochloride dihydrate [6028-07-5]; Down 200; 14.6uM; PC3; HT_HG-U133A	SPHK2 AVL9 PI4K2A CC2D1A BNC1 NF1 FAM13A NCOA1	2.75e-05	194	140	8	5076_DN
Drug	Clozapine [5786-21-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A	MBOAT7 FXR2 PDLIM7 PI4K2A SPART ADGRL1 NF1 ZFP36L2	2.75e-05	194	140	8	5630_DN
Drug	pioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A	MIER2 SPHK2 DVL2 PI4K2A NF1 ZFP36L2 TSC22D4 BTRC	2.75e-05	194	140	8	7523_UP
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A	TANC2 DEPP1 PER1 REST CREB5 FAM13A ATXN1 BTRC	2.75e-05	194	140	8	3725_DN
Drug	Indapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A	SPHK2 PDLIM7 MAST2 ZNF783 NF1 ZFP36L2 MYRF BTRC	2.75e-05	194	140	8	4335_DN
Drug	Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; PC3; HT_HG-U133A	TCF4 DEPP1 PI4K2A ABLIM1 NF1 ZFP36L2 ELF4 PLK4	2.75e-05	194	140	8	6651_DN
Drug	Moricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; HL60; HT_HG-U133A	PER1 ZNF783 SLC11A1 FAM13A EGR1 TSC22D4 KAT6B SPSB3	2.75e-05	194	140	8	2959_UP
Drug	Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A	TCF4 ARHGAP32 SLC2A8 FXR2 PDLIM7 PER1 ADGRL1 NF1	2.85e-05	195	140	8	1207_DN
Drug	Cefamandole sodium salt [30034-03-8]; Up 200; 8.2uM; PC3; HT_HG-U133A	PDLIM7 PI4K2A ADGRL1 CC2D1A NF1 ADGRL2 SPSB3 BTRC	2.85e-05	195	140	8	7394_UP
Drug	Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; PC3; HT_HG-U133A	ARHGAP32 DVL2 PI4K2A REST HIVEP3 NF1 FAM13A BTRC	2.85e-05	195	140	8	4502_DN
Drug	Dydrogesterone [152-62-5]; Down 200; 12.8uM; HL60; HT_HG-U133A	TCF4 ZNF783 NF1 SLC11A1 ZFP36L2 ELF4 SPSB3 BBOF1	2.85e-05	195	140	8	2156_DN
Drug	Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; MCF7; HT_HG-U133A	SLC2A8 PDLIM7 DVL2 ADGRL1 ATP13A2 ZNF783 NF1 SCNN1B	2.85e-05	195	140	8	2852_DN
Drug	Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A	SEMA4F SETD1A PDLIM7 MAST2 CRMP1 LRP1 TSC22D4 CTDSPL	2.85e-05	195	140	8	4326_DN
Drug	LY294002; Up 200; 10uM; PC3; HG-U133A	TCF4 MAST2 CRMP1 DOCK5 NF1 ZNF394 ATXN1 SPSB3	2.85e-05	195	140	8	429_UP
Drug	Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; HL60; HT_HG-U133A	REST MED1 F5 SF1 DOCK5 SLC11A1 ZFP36L2 KAT6B	2.85e-05	195	140	8	2708_DN
Drug	Propofol [2078-54-8]; Down 200; 22.4uM; PC3; HT_HG-U133A	PDLIM7 ADGRL1 REST HIVEP3 NF1 ZFP36L2 CTDSPL MYRF	2.85e-05	195	140	8	6707_DN
Drug	(S)-propranolol hydrochloride [4199-10-4]; Up 200; 13.6uM; HL60; HT_HG-U133A	BEST1 EPM2A SLC2A8 PDLIM7 DOCK5 FAM13A MYRF BTRC	2.96e-05	196	140	8	2961_UP
Drug	Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	MBOAT7 FXR2 PDLIM7 PER1 DIDO1 LIN37 NF1 ZFP36L2	2.96e-05	196	140	8	3416_DN
Drug	Graveoline [485-61-0]; Down 200; 14.4uM; PC3; HT_HG-U133A	SETD1A DPYSL3 PDLIM7 MAST2 HIVEP3 NF1 LRP1 TSC22D4	2.96e-05	196	140	8	3716_DN
Drug	Diprophylline [479-18-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	SPHK2 DVL2 SF1 DOCK5 NF1 TSC22D4 CTDSPL PLK4	2.96e-05	196	140	8	5063_DN
Drug	Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; PC3; HT_HG-U133A	EPM2A PDLIM7 PI4K2A HIC2 BNC1 FAM13A LRP1 BTRC	2.96e-05	196	140	8	4570_DN
Drug	Flurandrenolide [1524-88-5]; Up 200; 9.2uM; PC3; HT_HG-U133A	TANC2 STAB2 PER1 ZNF783 DOCK5 HIVEP3 LRP1 CTDSPL	2.96e-05	196	140	8	7378_UP
Drug	Enoxacin [74011-58-8]; Up 200; 12.4uM; MCF7; HT_HG-U133A	TCF4 PI4K2A F5 LDB3 NF1 ZFP36L2 EGR1 NR5A2	2.96e-05	196	140	8	5251_UP
Drug	3-aminobenzamide; Up 200; 10000uM; MCF7; HG-U133A	LIAS FXR2 CC2D1A ATP13A2 ZNF783 RBM14 NCOA1 FOXC1	2.96e-05	196	140	8	590_UP
Drug	Betonicine [515-25-3]; Up 200; 25.2uM; HL60; HT_HG-U133A	SEMA4F TCF4 STAB2 SPART ATP13A2 BNC1 ABLIM1 FAM13A	2.96e-05	196	140	8	2207_UP
Drug	Sisomicin sulfate [53179-09-2]; Down 200; 2.8uM; HL60; HT_HG-U133A	TCF4 MAST2 F5 NF1 SLC11A1 NCOA1 PLK4 SPSB3	2.96e-05	196	140	8	2493_DN
Drug	alpha-estradiol; Up 200; 0.01uM; HL60; HT_HG-U133A	DVL2 F5 ABLIM1 LDB3 SLC11A1 SPSB3 BTRC FOXC1	2.96e-05	196	140	8	6169_UP
Drug	Lactobionic acid [96-82-2]; Up 200; 11.2uM; HL60; HT_HG-U133A	SETD1A TCF4 PDLIM7 CC2D1A ATP13A2 ZFP36L2 NCOA1 KAT6B	3.07e-05	197	140	8	1309_UP
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	MIER2 SPHK2 STAB2 MAP2 ATG2A NF1 TSC22D4 TMC5	3.07e-05	197	140	8	3886_DN
Drug	Isoxicam [34552-84-6]; Up 200; 12uM; MCF7; HT_HG-U133A	TANC2 SPART MED1 MAST2 CRMP1 NF1 TSC22D4 PLK4	3.07e-05	197	140	8	1698_UP
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A	TANC2 SPHK2 PI4K2A PER1 ZNF783 HIVEP3 ZFP36L2 MYRF	3.07e-05	197	140	8	3748_DN
Drug	Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A	SLC2A8 ADGRL1 MAST2 LDB3 NF1 PLK4 SPSB3 BTRC	3.07e-05	197	140	8	7344_UP
Drug	Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; MCF7; HT_HG-U133A	MBOAT7 AVL9 REST ATG2A SF1 NCOA1 ELF4 SPSB3	3.07e-05	197	140	8	3411_DN
Drug	Phenindione [83-12-5]; Down 200; 18uM; MCF7; HT_HG-U133A	FXR2 PI4K2A ADGRL1 ZNF783 DOCK5 ABLIM1 KAT6B BTRC	3.07e-05	197	140	8	2868_DN
Drug	Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A	FXR2 PDLIM7 CC2D1A MAST2 HIVEP3 ABLIM1 NF1 CTDSPL	3.07e-05	197	140	8	5815_DN
Drug	Propidium iodide [25535-16-4]; Down 200; 6uM; PC3; HT_HG-U133A	SEMA4F ADGRL1 HIC2 HIVEP3 NF1 FAM13A ZFP36L2 EGR1	3.07e-05	197	140	8	5803_DN
Drug	Metoclopramide monohydrochloride [7232-21-5]; Up 200; 11.8uM; HL60; HT_HG-U133A	PER1 REST ZNF783 CRMP1 NF1 TSC22D4 TMC5 KAT6B	3.07e-05	197	140	8	2353_UP
Drug	Moxonidine [75438-57-2]; Down 200; 16.6uM; PC3; HT_HG-U133A	SETD1A DVL2 PI4K2A LRP1 NCOA1 CTDSPL SPSB3 BTRC	3.07e-05	197	140	8	4084_DN
Drug	Mimosine [500-44-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A	PDLIM7 PI4K2A RELA ATG2A ZNF783 DOCK5 ZFP36L2 SPSB3	3.07e-05	197	140	8	5302_UP
Drug	Lorglumide sodium salt [97964-56-2]; Up 200; 8.4uM; MCF7; HT_HG-U133A	STAB2 DVL2 PER1 ZNF783 LDB3 NF1 NR5A2 TSC22D4	3.18e-05	198	140	8	5254_UP
Drug	Meropenem [96036-03-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A	FXR2 CC2D1A REST MED1 EGR1 ELF4 CTDSPL FOXC1	3.18e-05	198	140	8	7180_DN
Drug	thioridazine hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	EPM2A SERTAD2 REST MED1 RBM14 ELF4 KAT6B FOXC1	3.18e-05	198	140	8	6989_DN
Drug	Primidone [125-33-7]; Down 200; 18.4uM; MCF7; HT_HG-U133A	BLNK PI4K2A PER1 SPART MED1 MAST2 ZFP36L2 CTDSPL	3.18e-05	198	140	8	3402_DN
Drug	5286656; Down 200; 50uM; MCF7; HT_HG-U133A_EA	SETD1A EPM2A SF1 NF1 ZFP36L2 TMC5 KAT6B SPSB3	3.18e-05	198	140	8	889_DN
Drug	Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A	FXR2 DVL2 PI4K2A ADGRL1 MED1 RNF14 NF1 ZFP36L2	3.18e-05	198	140	8	7482_DN
Drug	Amoxapine [14028-44-5]; Down 200; 12.8uM; MCF7; HT_HG-U133A	SETD1A EPM2A PDLIM7 ADGRL1 REST SF1 TMC5 BTRC	3.18e-05	198	140	8	1513_DN
Drug	Isoniazid [54-85-3]; Up 200; 29.2uM; PC3; HT_HG-U133A	EPM2A ATG2A CREB5 ZNF783 EGR1 LRP1 TSC22D4 MYRF	3.18e-05	198	140	8	2083_UP
Drug	2-propylpentanoic acid; Down 200; 500uM; MCF7; HG-U133A	SETD1A SPHK2 STAB2 FXR2 HIVEP3 KAT6B BTRC BBOF1	3.18e-05	198	140	8	347_DN
Drug	Canavanine sulfate monohydrate (L,+) [206996-57-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A	MBOAT7 PI4K2A PER1 CC2D1A HIC2 MED1 NF1 BTRC	3.18e-05	198	140	8	4782_UP
Drug	Nadide [53-84-9]; Down 200; 6uM; HL60; HT_HG-U133A	ARHGAP32 PDLIM7 ADGRL1 F5 DOCK5 NF1 SLC11A1 NR5A2	3.18e-05	198	140	8	2529_DN
Drug	Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A	SETD1A SPHK2 PER1 CC2D1A NF1 TSC22D4 CTDSPL MYRF	3.18e-05	198	140	8	4551_DN
Drug	Glafenine hydrochloride [65513-72-6]; Up 200; 9.8uM; MCF7; HT_HG-U133A	FXR2 PDLIM7 ADGRL1 MAST2 ATP13A2 NF1 EGR1 CTDSPL	3.18e-05	198	140	8	7018_UP
Drug	celecoxib; Up 200; 10uM; PC3; HG-U133A	TANC2 TCF4 SPART MAST2 SLA HIVEP3 SPSB3 BTRC	3.18e-05	198	140	8	482_UP
Drug	Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	MIER2 EPM2A AVL9 FXR2 PDLIM7 NF1 ZFP36L2 RPRD2	3.18e-05	198	140	8	7174_DN
Drug	Metixene hydrochloride [1553-34-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A	SEMA4F SETD1A MAST2 EGR1 NCOA1 ELF4 CTDSPL FOXC1	3.18e-05	198	140	8	3313_DN
Drug	clotrimazole; Down 200; 50uM; MCF7; HT_HG-U133A_EA	SETD1A SLC2A8 FXR2 HIC2 SF1 ZFP36L2 ELF4 SPSB3	3.18e-05	198	140	8	905_DN
Drug	Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A	PDLIM7 PER1 ZNF783 PHF2 NF1 TSC22D4 TMC5 SPSB3	3.18e-05	198	140	8	7349_UP
Drug	nordihydroguaiaretic acid; Down 200; 1uM; ssMCF7; HG-U133A	LIAS FXR2 CC2D1A ASCL3 SLA ATP13A2 F5 NCOA1	3.18e-05	198	140	8	415_DN
Drug	Pyrimethamine [58-14-0]; Down 200; 16uM; PC3; HT_HG-U133A	DVL2 PI4K2A CC2D1A ATP13A2 HIVEP3 ZFP36L2 RPRD2 ELF4	3.18e-05	198	140	8	4194_DN
Drug	Tubocurarine chloride pentahydrate (+) [6989-98-6]; Up 200; 5.2uM; PC3; HT_HG-U133A	PI4K2A PER1 RELA REST MAST2 F5 FAM13A ZFP36L2	3.18e-05	198	140	8	6351_UP
Disease	Neurodevelopmental Disorders	TANC2 TCF4 HIVEP3 PHF2 KMT2C ZC3H4	4.91e-06	93	137	6	C1535926
Disease	attention deficit hyperactivity disorder (implicated_via_orthology)	PER1 ADGRL1 NF1 ADGRL2	8.35e-06	28	137	4	DOID:1094 (implicated_via_orthology)
Disease	Microphthalmos	BEST1 KMT2D MYRF	1.57e-05	11	137	3	C0026010
Disease	Kleefstra syndrome 2 (implicated_via_orthology)	KMT2C KMT2D	2.14e-05	2	137	2	DOID:0080598 (implicated_via_orthology)
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Positive	MAP2 AVL9 PER1 SLC11A1 EGR1 KAT6B	3.49e-05	131	137	6	C4704862
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Negative	MAP2 AVL9 PER1 SLC11A1 EGR1 KAT6B	3.49e-05	131	137	6	C4552091
Disease	Juvenile arthritis	MAP2 AVL9 PER1 SLC11A1 EGR1 KAT6B	3.49e-05	131	137	6	C3495559
Disease	Juvenile psoriatic arthritis	MAP2 AVL9 PER1 SLC11A1 EGR1 KAT6B	3.49e-05	131	137	6	C3714758
Disease	Juvenile-Onset Still Disease	MAP2 AVL9 PER1 SLC11A1 EGR1 KAT6B	4.13e-05	135	137	6	C0087031
Disease	myofibrillar myopathy 4 (implicated_via_orthology)	PDLIM7 LDB3	6.40e-05	3	137	2	DOID:0080095 (implicated_via_orthology)
Disease	diacylglycerol 38:3 measurement	BEST1 MBOAT7 MYRF	8.98e-05	19	137	3	EFO_0020065
Disease	Colorectal Carcinoma	MYC MAP2 PER1 GRID1 STAM F5 HIVEP3 KMT2C NF1 ZFP36L2 SCNN1B LRP1	1.11e-04	702	137	12	C0009402
Disease	temperament and character inventory	SLA EGR2 ADGRL2	1.85e-04	24	137	3	EFO_0004825
Disease	cardiomyopathy (implicated_via_orthology)	SPHK2 PDLIM7 LDB3 LRP1	3.40e-04	71	137	4	DOID:0050700 (implicated_via_orthology)
Disease	monocyte count	TCF4 STAB2 FXR2 SERTAD2 DIDO1 ARHGAP9 REST MAST2 CREB5 HIVEP3 NF1 ATXN1 WASF2 NR5A2 NCOA1 CTDSPL	4.27e-04	1320	137	16	EFO_0005091
Disease	Spinocerebellar Ataxia Type 2	SCYL1 ATXN1 FOXC1	5.27e-04	34	137	3	C0752121
Disease	Spinocerebellar Ataxia Type 1	SCYL1 ATXN1 FOXC1	5.27e-04	34	137	3	C0752120
Disease	Spinocerebellar Ataxia Type 5	SCYL1 ATXN1 FOXC1	5.27e-04	34	137	3	C0752123
Disease	Spinocerebellar Ataxia Type 7	SCYL1 ATXN1 FOXC1	5.27e-04	34	137	3	C0752125
Disease	Spinocerebellar Ataxia Type 6 (disorder)	SCYL1 ATXN1 FOXC1	5.27e-04	34	137	3	C0752124
Disease	Ataxia, Spinocerebellar	SCYL1 ATXN1 FOXC1	5.27e-04	34	137	3	C0087012
Disease	Spinocerebellar Ataxia Type 4	SCYL1 ATXN1 FOXC1	5.75e-04	35	137	3	C0752122
Disease	Liver carcinoma	MYC STAB2 DCAF4L2 LCAT MED1 KMT2C EGR1 EGR2 LILRB5	6.25e-04	507	137	9	C2239176
Disease	testosterone measurement	FXR2 NTAQ1 SERTAD2 ARHGAP9 DOCK5 NF1 ZNF394 EGR1 EGR2 ZC3H4 CNKSR3 PALM3 NCOA1 ADGRL2 FOXC1	8.81e-04	1275	137	15	EFO_0004908
Disease	level of Phosphatidylcholine (18:0_22:5) in blood serum	BEST1 MYRF	9.40e-04	10	137	2	OBA_2045096
Disease	social interaction measurement	TCF4 ZDHHC5 FBXL17 PHF2	9.82e-04	94	137	4	EFO_0009592
Disease	venous thromboembolism, von Willebrand factor measurement	STAB2 F5 MYRF	9.85e-04	42	137	3	EFO_0004286, EFO_0004629
Disease	Squamous cell carcinoma of esophagus	DIDO1 KMT2C FAT2 KMT2D	1.02e-03	95	137	4	C0279626
Disease	bladder exstrophy	LIAS CREB5 ADGRL2	1.13e-03	44	137	3	MONDO_0010805
Disease	reticulocyte count	SPHK2 TPCN2 HECTD4 SERTAD2 ARHGAP9 REST MAST2 DOCK5 ATXN1 ZFP36L2 ZC3H4 PALM3 MYRF	1.19e-03	1045	137	13	EFO_0007986
Disease	cholesteryl ester 20:2 measurement	BEST1 MYRF	1.37e-03	12	137	2	EFO_0021440
Disease	neuroimaging measurement	TCF4 DPYSL3 TPCN2 MAP2 RBM26 ZDHHC5 STAM ATP13A2 CRMP1 ABLIM1 NF1 CNKSR3 TMC5	1.46e-03	1069	137	13	EFO_0004346
Disease	salicylurate measurement	SLAIN2 ABLIM1	1.61e-03	13	137	2	EFO_0010532
Disease	breast cancer (biomarker_via_orthology)	MYC EGR1	1.61e-03	13	137	2	DOID:1612 (biomarker_via_orthology)
Disease	phosphatidylcholine ether measurement	BEST1 MYRF	1.61e-03	13	137	2	EFO_0010227
Disease	level of Phosphatidylcholine (18:1_20:2) in blood serum	BEST1 MYRF	1.88e-03	14	137	2	OBA_2045102
Disease	diacylglycerol 38:4 measurement	MBOAT7 MYRF	1.88e-03	14	137	2	EFO_0020066
Disease	Antithrombotic agent use measurement	HECTD4 F5 PRDM8	2.15e-03	55	137	3	EFO_0009925
Disease	phosphatidate measurement	MBOAT7 MYRF	2.16e-03	15	137	2	EFO_0020047
Disease	von Willebrand factor measurement, coronary artery disease	STAB2 HECTD4 PRDM8 MYRF	2.27e-03	118	137	4	EFO_0001645, EFO_0004629
Disease	hair colour measurement	TPCN2 ATG2A CREB5 BNC1 ZNF750 KMT2D FAM13A RBM27 LRP1	2.37e-03	615	137	9	EFO_0007822
Disease	Alzheimer's disease (implicated_via_orthology)	MAP2 HIVEP3 LRP1	2.39e-03	57	137	3	DOID:10652 (implicated_via_orthology)
Disease	Prostatic Neoplasms	MYC STAB2 KMT2C KMT2D ZFP36L2 EGR1 NCOA1 RPRD2 FOXC1	2.40e-03	616	137	9	C0033578
Disease	Malignant neoplasm of prostate	MYC STAB2 KMT2C KMT2D ZFP36L2 EGR1 NCOA1 RPRD2 FOXC1	2.40e-03	616	137	9	C0376358
Disease	colon cancer (is_marker_for)	NF1 NR5A2 PLK4	2.63e-03	59	137	3	DOID:219 (is_marker_for)
Disease	hematocrit	SLAIN2 HECTD4 SERTAD2 MAST2 PRDM8 FAM13A EGR2 ZC3H4 NR5A2 TMC5 CTDSPL MYRF	2.71e-03	1011	137	12	EFO_0004348
Disease	loneliness measurement	TCF4 DPYSL3 EPM2A PHF2	2.71e-03	124	137	4	EFO_0007865
Disease	Brain Ischemia	RELA F5 EGR1	2.76e-03	60	137	3	C0007786
Disease	Cerebral Ischemia	RELA F5 EGR1	2.76e-03	60	137	3	C0917798
Disease	phosphatidylcholine 40:6 measurement	TMC5 MYRF	2.78e-03	17	137	2	EFO_0010389
Disease	Familial Progressive Myoclonic Epilepsy	EPM2A PRDM8	2.78e-03	17	137	2	C0751777
Disease	Atypical Inclusion-Body Disease	EPM2A PRDM8	2.78e-03	17	137	2	C0751776
Disease	Myoclonic Epilepsies, Progressive	EPM2A PRDM8	2.78e-03	17	137	2	C0751778
Disease	Biotin-Responsive Encephalopathy	EPM2A PRDM8	2.78e-03	17	137	2	C0751780
Disease	May-White Syndrome	EPM2A PRDM8	2.78e-03	17	137	2	C0751782
Disease	Dentatorubral-Pallidoluysian Atrophy	EPM2A PRDM8	2.78e-03	17	137	2	C0751781
Disease	ischemia (implicated_via_orthology)	SF1 SCNN1B	2.78e-03	17	137	2	DOID:326 (implicated_via_orthology)
Disease	CCL2 measurement	SERTAD2 FBXL17 HIVEP3 ZC3H4	2.87e-03	126	137	4	EFO_0004749
Disease	Action Myoclonus-Renal Failure Syndrome	EPM2A PRDM8	3.12e-03	18	137	2	C0751779
Disease	level of Phosphatidylcholine (16:0_22:5) in blood serum	BEST1 MYRF	3.12e-03	18	137	2	OBA_2045079
Disease	response to bronchodilator, FEV/FEC ratio	TCF4 GRID1 ATG2A DOCK5 LDB3 FAT2 FAM193A FAM13A CNKSR3 TMEM200C	3.13e-03	766	137	10	EFO_0004713, GO_0097366
Disease	body surface area	TPCN2 PER1 DIDO1 GRID1 ATP13A2 CREB5 DOCK5 ZC3H4 CTDSPL	3.18e-03	643	137	9	EFO_0022196
Disease	factor VIII measurement, Ischemic stroke	STAB2 HECTD4	3.47e-03	19	137	2	EFO_0004630, HP_0002140
Disease	Seizures	TANC2 TCF4 REST KCNK4 TET3	3.57e-03	218	137	5	C0036572
Disease	stem Cell Factor measurement	LCAT F5 MYRF	3.78e-03	67	137	3	EFO_0008291
Disease	neutrophil count, basophil count	HECTD4 MAST2 CREB5 ATXN1 NCOA1	4.01e-03	224	137	5	EFO_0004833, EFO_0005090
Disease	diastolic blood pressure, systolic blood pressure	TPCN2 PSMB4 SCYL1 FBXL17 ARHGAP9 CREB5 DOCK5 LRP1 BTRC	4.16e-03	670	137	9	EFO_0006335, EFO_0006336
Disease	skin hydration measurement	MYC ABLIM1	4.24e-03	21	137	2	EFO_0009586
Disease	level of Phosphatidylcholine (18:1_20:4) in blood serum	BEST1 MYRF	4.24e-03	21	137	2	OBA_2045104
Disease	level of Phosphatidylinositol (18:0_18:2) in blood serum	BEST1 MBOAT7	4.24e-03	21	137	2	OBA_2045156
Disease	advanced glycosylation end product-specific receptor ligand measurement	FAM13A PRRT1B	4.24e-03	21	137	2	EFO_0010762
Disease	level of Phosphatidylcholine (16:0_20:4) in blood serum	BEST1 MYRF	4.24e-03	21	137	2	OBA_2045076
Disease	level of Phosphatidylcholine (16:1_18:2) in blood serum	BEST1 MYRF	4.24e-03	21	137	2	OBA_2045083
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	TCF4 EPM2A BLNK FBXL17 REST BNC1 FAM13A KIAA1328 ADGRL2 TET3	4.28e-03	801	137	10	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	cigarettes per day measurement	SETD1A TCF4 FBXL17 CREB5 PHF2 RBM27 CNKSR3	4.47e-03	438	137	7	EFO_0006525

Protein segments in the cluster

Peptide	Gene	Start	Entry
PTDSLDPYSAPGRLP	EPM2A	221	B3EWF7
PRAQPSSASYQPVPA	AMOT	411	Q4VCS5
PTAQVYEFPDPPTSA	CASS4	126	Q9NQ75
PDSRPLTPTYAQAPK	ABLIM1	496	O14639
TEERLSTPHPYPSPQ	AIFM3	51	Q96NN9
PPPSPSLDDYVRSIS	DEPP1	31	Q9NTK1
LRDSPSYPDSSPEGP	ADGRL1	1391	O94910
SYPDSSPEGPSEALP	ADGRL1	1396	O94910
AATAALYPSPSLQPP	FEV	206	Q99581
PLSPDPTTPDYINSL	DPYSL3	306	Q14195
PAAQAEPPRSPSRTY	BTRC	586	Q9Y297
QPVLPFYRSPATPAE	BNC1	486	Q01954
PNLRDSPYPESSPDM	ADGRL2	1376	O95490
PEPQPPYTAASAQFR	BEST1	341	O76090
SRLSNYPEPPPSALV	DNHD1	2316	Q96M86
DYSPPSAPRSVPVAT	ATXN1	86	P54253
PSRKYNQSSRPPVPD	BBOF1	461	Q8ND07
PAPDYLAERSPPSVS	FAM193A	246	P78312
DPSPQAYFTLPRNEP	DVL2	356	O14641
SLSLPERPEAPPSYA	ARRDC3	336	Q96B67
PPLYSEIDPNPDQSA	ARRDC3	391	Q96B67
FAPPAQLAPTIYPSE	ATG2A	1011	Q2TAZ0
PPRASYVAPLTAQPA	RBM14	221	Q96PK6
PPAPPSLFTADTYDT	RBM26	416	Q5T8P6
LESSYVPVSAPPPNS	RBM27	211	Q9P2N5
LDLPYPSSFAPVSAP	EGR2	71	P11161
PAPGQFYRIPSTPDS	PSMB4	16	P28070
TYAPARQPEPSAPTE	PALM3	641	A6NDB9
QYPSAFPSSLPPVSL	KAT6B	186	Q8WYB5
QGYLSPESSPPASPV	CREB5	451	Q02930
PDIYSSNKDLPPETP	REST	131	Q13127
STTNNDPYAKPPDTP	KMT2C	1956	Q8NEZ4
TISRPTSQDPYSQPP	KMT2C	2121	Q8NEZ4
PSEPEPSPSTLIYRN	LIN37	196	Q96GY3
SPADSPRPQASSYSP	LDB3	356	O75112
SNPYSLLDTSEPEPP	FXR2	516	P51116
PDSDPAPAVTLPNYL	ELF4	121	Q99607
SDPDPAAYPSTAGRP	MAPK8IP1	311	Q9UQF2
AQPPSPPTASALDYP	KCNK4	326	Q9NYG8
YRSLPPAAPPTTSNR	LRP1	3926	Q07954
SATSPDLNPPQDPYR	TCF4	481	P15884
TIPSPYPASENDIPS	DCAF4L2	351	Q8NA75
PIYSAAPTFPTPNTD	EGR1	201	P18146
SPTVAPDPAPDAYRP	PER1	761	O15534
EPSAPSIPTPAYQSS	PDCD6IP	716	Q8WUM4
SDPDSPENGPPYSFR	FAT2	3451	Q9NYQ8
PPPSSPEKAASLEYD	MBOAT7	281	Q96N66
NPPPLDASEPYNTAK	LIAS	151	O43766
SPGPQQAPPRETYLS	SLC11A1	26	P49279
PSQEREPPAEPSIYA	LILRB5	571	O75023
YDPPAESQQSESPPR	KLC3	156	Q6P597
DQPVYTVSLPENSPP	PCDH10	251	Q9P2E7
YPRDASPANTGLAPP	HECTD4	2641	Q9Y4D8
DQSPPRFYSGDQPPS	ARHGAP32	1201	A7KAX9
SRQYLDDTEVPPSPP	FAM13A	626	O94988
PQKASAPAADPPRYT	PDLIM7	91	Q9NR12
APAADPPRYTFAPSV	PDLIM7	96	Q9NR12
APPYFLSNLPPSESR	DQX1	671	Q8TE96
SPNSAPKPQRYPSRE	KIAA1328	521	Q86T90
PLVSPERAQPPDYTF	PI4K2A	6	Q9BTU6
DPTVLSPPSLYPSVD	BTBD18	241	B2RXH4
PDQAASYTVEPDPRS	ATP13A2	806	Q9NQ11
DENYIHPTESSSPPP	BLNK	186	Q8WV28
PYEGSQRNSTELAPP	DOCK5	1826	Q9H7D0
RDYNVEAPPPSSPSV	CTDSPL	51	O15194
DPLPDYSLPPVTSSS	FOXC1	426	Q12948
TAPYSLGRPDPNPSL	FRMPD3	861	Q5JV73
PLSPPPRDGAYAAAS	FBXL17	81	Q9UF56
DTNQYLKPPSRPSPD	AVL9	311	Q8NBF6
TYSPAPTQPAPRIAS	CC2D1A	206	Q6P1N0
DPRYLSVPPSPNIST	DIDO1	1021	Q9BTC0
SPYSEELPRLPFPSD	ASCL3	46	Q9NQ33
DFNIPSPAASAPPAY	MS4A15	216	Q8N5U1
QPPSAPRLAHPSYED	MAST2	1706	Q6P0Q8
NPSPDGEAYTLASRP	GRID1	131	Q9ULK0
AYRQGPPASPTASPE	LCAT	421	P04180
PDPESSHSPPRYTDQ	COQ9	71	O75208
VPTDAPPPYSLTDSC	BEAN1	161	Q3B7T3
PPGRDESYPRELSNS	RPRD2	771	Q5VT52
PRSPNTGPYPSEQAL	SCNN1B	596	P51168
PLSPDPTTPDYLTSL	CRMP1	306	Q14194
PAAVHYQPASPPRDA	NTAQ1	6	Q96HA8
YQNSPSSDDGIRPLP	MED1	1476	Q15648
PPALADPASYQPAVT	MIER2	446	Q8N344
PPTDYDRSPFVTSPI	NR5A2	231	O00482
SDYPSPDISPPIFRR	SLA	31	Q13239
PPAASAPPVANSASY	HIC2	281	Q96JB3
YFQSVSASDPPPRPS	SEL1L3	1081	Q68CR1
ALEYNPSSQPPASPS	PHF2	776	O75151
YPAVNRFSPSPRNSP	SLAIN2	336	Q9P270
SYSQDPPSPSPEDER	SEMA4F	711	O95754
PQEAPSQPPATYSLV	SCIMP	96	Q6UWF3
STSGLPDYRAPPSPE	TMEM200C	471	A6NKL6
PPLDSRPSSPALYFT	TSC22D4	256	Q9Y3Q8
SQEPPPDGTRLASEY	SCYL1	711	Q96KG9
PPPDLDQIFYPSESS	F5	1456	P12259
PSVVFPYPLNDSSSP	MYC	191	P01106
ERPNLYSQPYSSPSP	NCOA1	986	Q15788
YSSPAIPSLQRAAPP	SLC2A8	46	Q9NY64
YPSPSPESSNPSAAA	PRDM8	236	Q9NQV8
VTPTAPPYLQESSPR	PIP4P2	21	Q8N4L2
ESSPRAELPPPYTAI	PIP4P2	31	Q8N4L2
CPSPEARSPEAPAYR	PRKY	31	O43930
QSPPSSPPHRDSAYI	TANC2	1441	Q9HCD6
SDSDPEYSTLPPSIP	SPSB3	46	Q6PJ21
QPSDPTNTYARPAEP	SGMS2	16	Q8NHU3
LSPPPSVDSNYPTRE	PLK4	816	O00444
SYLPPEPSRPTDQDY	SETD1A	411	O15047
EPSRPTDQDYRPPAS	SETD1A	416	O15047
TDQDYRPPASEAPPP	SETD1A	421	O15047
VSPANAPSAYPRPSS	SERPINA9	21	Q86WD7
PPIIEESSSPPYRFS	CNKSR3	471	Q6P9H4
YRESSSCPNILEPPP	C15orf62	86	A8K5M9
VYPASSPSRLNPSDP	ZNF750	356	Q32MQ0
NFELPPDYPSSSPPS	RNF14	76	Q9UBS8
LPSQSCPAEAPPAYT	SPART	161	Q8N0X7
PNYPAASPDPETSRL	ZNF394	51	Q53GI3
EPGPQPAPSSASAYR	XKR7	156	Q5GH72
PSYPPARPASTLNVA	SYNPO2	811	Q9UMS6
SDLNKYSPPPQSPEL	NAA35	641	Q5VZE5
LSYLPATVEPASPTP	SPHK2	376	Q9NRA0
PSTEPLGYSSQDPRE	SPEM2	366	Q0P670
QPTTEPSDSYREAPP	SERTAD2	91	Q14140
NSLYDPESPVTPSTP	RELL1	141	Q8IUW5
YSSDIRLPPVAPPAS	HIVEP3	1281	Q5T1R4
SEESLLTPTSPYPPA	NF1	2751	P21359
SYQALSPPSRDSPEP	PRRT4	851	C9JH25
NPLYESTTSAPPEPS	STAB2	2516	Q8WWQ8
QAPVYSPPPAATAAA	STAM	476	Q92783
SAGDASLQDPPSYPP	TMEM44	401	Q2T9K0
SLVFYREPPPTAPSS	ARHGAP9	356	Q9BRR9
EALSPPAPFRSPQSY	TET3	386	O43151
PAPFRSPQSYLRAPS	TET3	391	O43151
GDASPPATAPYDPRV	ZC3H4	1111	Q9UPT8
AQSYPSDLPEEPSSP	MAP2	641	P11137
VDASSYPPPPQSDSA	WASF2	241	Q9Y6W5
SSPVPYLSPETNPAS	TJP1	926	Q07157
LEEPTPAPSTSYSPQ	TJP1	956	Q07157
PDPPLGYTSPFLSAR	ZDHHC5	491	Q9C0B5
PLSTEPPAAPATSAY	ZNF687	656	Q8N1G0
RTSPDHPTSLPEPDY	TMC5	96	Q6UXY8
VFRTPPYADPSLQAP	RELA	251	Q04206
PPSPPDSLSDRDSYL	ZFP36L2	446	P47974
AQLYPAAPTPPALFS	PRRT1B	141	A0A1B0GWB2
PEDRSPSPEPIYNSE	SF1	76	Q15637
HPPRPEYQSPFLQSA	TPCN2	411	Q8NHX9
PSTPLPQPAAEKNSY	ZNF783	21	Q6ZMS7
TPRFQSPDPYSRPPS	KMT2D	2441	O14686
PPASPSYPRAEPLTA	KIAA1522	976	Q9P206
SYPRAEPLTAPPTNG	KIAA1522	981	Q9P206
PRDFSTYRPLPDPSV	MYORG	471	Q6NSJ0
PDSPPDSGSEAYSPQ	MYRF	136	Q9Y2G1